https://rjrindex.com/articles/outcomes-and-treatment-strategies-following-cd20cd3-bispecific-antibody-failure-in-non-hodgkins-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-and-preliminary-efficacy-of-a-mediterranean-diet-and-home-based-exercise-intervention-du 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-exact-system-for-precision-clinical-trial-matching-case-study-of-accuracy-with-follicular-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/denatured-albumin-is-a-potent-ligand-mediating-platelet-activaiton-adhesion-and-aggregation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subtype-specific-son-isoform-expression-in-acute-myeloid-leukemia-revealed-by-targeted-long-read-rna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiac-risk-factors-and-cardiac-events-in-patients-with-newly-diagnosed-amyloid-light-chain-al-am 2026-08-17 monthly 0.7 https://rjrindex.com/articles/harnessing-phagocytes-for-amyloid-clearance-development-of-a-novel-bispecific-phagocyte-engager-lc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disease-monitoring-and-management-among-pediatric-patients-with-pyruvate-kinase-deficiency-real-wor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-wgs-based-circulating-tumor-dna-ctdna-monitoring-in-diffuse-large-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/geographic-and-temporal-trends-in-sickle-cell-disease-hospitalizations-in-new-york-state 2026-08-17 monthly 0.7 https://rjrindex.com/articles/endocrine-adverse-events-following-car-t-cell-therapies-a-pharmacovigilance-analysis-in-the-real-wo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-induction-regimen-and-co-mutations-on-outcomes-in-aml-with-myelodysplasia-related-changes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-of-iron-deficiency-among-youth-with-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-ferroptosis-in-agvhd-induced-liver-tissue-damage-mediation-by-acsl4-regulated-pufa-pls 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-in-vitro-hepcidin-fpn-axis-model-for-exploring-the-role-of-macronutrients-in-cellular-iron-transp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/checkpoint-inhibitors-exposure-does-not-affect-survival-and-safety-in-pmbcl-patients-receiving-car-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-hemostasis-factor-viii-deficiency-impacts-hematopoietic-stem-cells-development-in-zebrafish 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-myd88l265p-in-extranodal-manifestations-of-b-cell-non-hodgkin-lymphomas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ascertaining-sickle-cell-disease-comparing-electronic-health-record-and-genomic-data-in-the-all-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-structured-peer-support-intervention-stepp-for-patients-undergoing-hematopoietic-stem-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombopoietin-inhibition-abrogates-jak2v617f-clonal-expansion-in-a-murine-model-of-myeloproliferati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-study-design-of-a-randomized-phase-3-trial-evaluating-the-efficacy-and-safety-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phenotypic-spectrum-and-treatment-outcomes-in-russian-gaucher-disease-patients-real-world-experienc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanistic-insights-into-how-g-protein-coupled-receptor-kinases-grks-regulate-thrombopoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gene-expression-based-prediction-of-1q-1p-13q-and-17p-chromosome-ploidy-in-newly-diagnosed-and-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilization-of-guidelines-and-educational-resources-in-telomere-biology-disorders-patterns-of-infor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/being-an-adult-with-shwachman-diamond-syndrome-an-analysis-of-36-german-patients-registered-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-short-form-case-based-continuing-medical-education-on-community-clinicians-knowledge-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-quality-improvement-curriculum-for-hematologyoncology-fellows-in-an-academic-training 2026-08-17 monthly 0.7 https://rjrindex.com/articles/investigating-suspected-germline-stag2-variants-in-myeloid-neoplasms 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-selinexor-sequential-azacytidine-in-newly-diagnosed-patients-with-myelodyspla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inflammatory-and-metabolic-gene-signatures-predict-overall-survival-and-response-to-venetoclax-based 2026-08-17 monthly 0.7 https://rjrindex.com/articles/construction-and-evaluation-of-a-prognostic-model-for-patients-with-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-burden-and-risk-analysis-of-hematologic-iraes-in-patients-treated-with-immune-checkpoint 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-projections-of-multiple-myeloma-mortality-in-the-united-states2024-2040-a-time-series 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-poor-prognostic-impact-of-del1p32-in-newly-diagnosed-multiple-myeloma-among-asian-popul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clptm1l-a-candidate-therapeutic-target-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-low-dose-vs-standard-dose-direct-oral-anticoagulants-for-secondary-preventio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gender-disparities-in-first-author-representation-across-ash-submissions-2019-2024 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitapivat-improves-red-blood-cell-integrity-by-reducing-membrane-ubiquitination-accumulation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-in-chinese-multiple-myeloma-patients-treated-with-daratumumab-based-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-second-primary-malignancies-spms-following-bispecific-antibody-bsab-therapy-for-lym 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-dose-chemotherapy-for-induction-in-pediatric-aml-retrospective-outcome-analysis-across-expanded 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-of-ndmm-patients-treated-with-daratumumab-lenalidomide-bortezomib-and-dexamethaso 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-consecutive-versus-alternate-day-schedules-of-high-dose-cytarabine-consolidation-chemo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adult-acute-myeloid-leukemia-with-fuserg-fusion-a-national-retrospective-multi-center-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bucy-combined-with-cladribine-and-medium-dose-cytarabine-as-an-intensified-conditioning-regimen-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-vpac12-targeted-antagonist-preferentially-binds-to-activated-t-cells-and-enhances-t-cell-activat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ubtf-tandem-duplications-generate-a-nuclear-export-signal-motif-that-drives-an-xpo1-dependency-in-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interest-barriers-and-motivators-for-pursuing-hematology-electives-among-fourth-year-caribbean-med 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deep-immune-signature-of-immune-mediated-aplastic-anemia-patients-shows-distinct-subsets-of-regulato 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pan-leukemia-3d-genomic-profile-reveals-extreme-long-polycomb-loop-in-subset-of-cebpa-mutated-amls-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-biological-differences-between-two-clinical-risk-groups-of-cutaneous-cd30-t-cell-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-ribonucleotide-reductase-to-overcome-flt3-inhibitor-resistance-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-single-cell-rna-sequencing-and-tcr-profiling-identifies-immune-drivers-of-severe-early-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-the-compass-complex-to-overcome-resistance-in-kmt2a-rearranged-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rbc-cultured-from-immortalized-erythroblasts-that-express-ectopic-antigens-induce-antigen-specific-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-trial-of-gt719-a-novel-stem-cell-derived-allogeneic-anti-cd19-car-inkt-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-effects-of-malt1-inhibitor-and-selinexor-on-acute-myeloid-leukemia-cells-and-the-underly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-richter-transformation-rt-treated-with-frontline-chemoimmunotherapy-cit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-metformin-on-the-incidence-of-thrombotic-events-in-older-patients-with-polycythemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bispecific-antibodies-in-real-world-care-of-multiple-myeloma-patient-characteristics-and-healthcare 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-traumatic-stress-disorder-in-patients-with-multiple-myeloma-mm-and-non-hodgkin-lymphoma-nhl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/limited-diagnostic-utility-of-abdominal-fat-pad-biopsy-for-systemic-amyloidosis-a-single-institutio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/minimally-invasive-assessment-of-peripheral-residual-disease-prd-during-maintenance-or-observation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimating-incident-and-prevalent-essential-thrombocythemia-patients-eligible-for-cytoreductive-ther 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utilizing-the-complete-blood-count-cbc-and-blood-smear-analysis-to-improve-pediatric-residents-sk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luspatercept-for-the-treatment-of-myelodysplastic-syndrome-a-retrospective-cohort-study-utilizing-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/palbociclib-combined-with-venetoclax-and-azacitidine-in-nup98-rearranged-pediatric-aml-a-multicente 2026-08-17 monthly 0.7 https://rjrindex.com/articles/triptonide-and-bortezomib-synergistically-inhibit-multiple-myeloma-by-enhancing-dna-damage-through-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-fli1-accessibility-mediates-stag2-mutant-leukemogenesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-survival-in-chronic-myeloid-leukemia-a-systematic-review-of-secondary-malignancies-in-the-er 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plattform-a-multicenter-multi-arm-academic-platform-trial-evaluating-novel-agents-and-combination 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-letermovir-for-the-prevention-of-cmv-infection-after-haploidentical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-lymphoblastic-lymphoma-presenting-as-pericardial-tamponade-a-rare-initial-manifestation-of-an-agg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-online-education-in-obstetric-hematology-significantly-improves-resident-knowledge-and-addr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/barriers-and-bridges-real-world-car-t-delivery-across-us-oncology-practices 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-recombinant-adjuvant-zoster-vaccine-induces-similar-immune-responses-in-ruxolitinib-treated-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-targeted-long-read-sequencing-as-a-diagnostic-tool-for-burkitt-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cells-targeting-cd79b-and-cd19-exhibit-robust-antitumour-activity-against-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcl-2-inhibitor-tqb3909-combined-with-jak-inhibitors-in-patients-with-intermediate-or-high-risk-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/determinants-of-response-of-the-bcmagprc5d-dual-targeting-t-cell-redirecting-trispecific-antibody-j 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-factor-viii-trough-levels-of-severe-type-people-with-hemophilia-a-pwha-on-efanesoctocog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcome-of-adult-b-precursor-acute-lymphoblastic-leukemia-all-treated-with-blinatumomab-in-additio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-cell-free-dna-and-rna-sequencing-recapitulates-bone-marrow-genomic-and-transcriptomic-alt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/refined-genetic-risk-model-with-complex-karyotype-predicts-outcomes-of-newly-diagnosed-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-lrf-degrader-induces-fetal-hemoglobin-expression-in-adult-erythroblasts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanisms-of-immune-escape-and-altered-tissue-homing-in-leukemia-cutis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asciminib-and-pregnancy-in-cml-preliminary-human-data-and-clinical-implications-from-47-reported-ou 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-treatment-duration-and-safety-of-axatilimab-among-patients-with-chronic-graft-versus-host 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-spleen-tyrosine-kinase-inhibitors-in-chronic-immune-thrombocytopenic-purpura 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-linperlisib-in-adult-patients-with-primary-immune-thrombocytopenia-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-pf4heparin-complexes-drive-platelet-activation-in-heparin-induced-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-open-label-multicenter-study-of-sonrotoclax-bgb-11417-plus-anti-cd20-antib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hepatic-plasminogen-lowering-with-a-galnac-conjugated-sirna-reduces-plasmin-generation-and-fibrinoly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cell-therapy-referral-patterns-and-characteristics-of-patients-with-relapsed-or-refractory-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/humanized-cd19-chimeric-antigen-receptor-car-t-cell-therapy-for-high-risk-and-post-car-relapse-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-correction-of-the-sickle-cell-disease-mutation-in-hematopoietic-stem-cells-using-rna-gene-wr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-mitapivat-in-patients-with-transfusion-dependent-alpha-thalassemia-subgroup-analysis-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burden-and-characteristics-of-infections-in-patients-treated-with-bispecific-antibodies-and-the-impa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-results-from-realital-a-multi-country-observational-retrospective-study-of-talquetamab-in-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multi-center-study-of-a-machine-learning-algorithm-for-identifying-undiagnosed-patients-with-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identifying-candidates-for-outpatient-administration-of-ciltacabtagene-autoleucel-cilta-cel-in-rel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/performance-of-the-eln-2022-risk-stratification-in-a-real-world-canadian-aml-patient-population 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitochondrial-hyperactivity-predicts-chemotherapy-relapse-and-venetoclax-resistance-in-pediatric-b-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mgus-like-phenotype-in-patients-with-al-amyloidosis-impact-on-clinical-outcomes-for-patients-treate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-mecom-rearranged-aml-undergoing-intensive-chemotherapy-in-the-ncri-aml17-and-aml19-trial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reduced-chronic-graft-versus-host-disease-after-allogeneic-hsct-with-cryopreserved-peripheral-blood 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-prognostic-value-of-car-hematox-in-predicting-toxic-events-in-patients-with-relapsed-refractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/theta-oscillation-attenuation-as-an-electroencephalogram-biomarker-for-intracranial-infections-in-he 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-primary-cns-prophylaxis-in-high-cns-ipi-dlbcl-analysis-from-the-czech-national-lymphoma-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/peripheral-plasmablast-expansion-as-a-predictor-and-therapeutic-target-in-chronic-gvhd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-variants-and-hemoglobinopathies-among-indian-sickle-cell-disease-patients-a-systematic-revi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/raising-pre-transfusion-hbs-levels-from-30-to-50-does-not-increase-ischemic-stroke-recurrence-in-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-prediction-model-for-maternal-pregnancy-complications-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiovascular-outcomes-in-cll-patients-receiving-glp-1-agonists-and-btk-inhibitors-a-global-prope 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reassessing-bone-marrow-staging-practices-in-limited-stage-follicular-lymphoma-in-the-pet-era 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-extreme-heat-exposures-and-survival-in-patients-with-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-analysis-of-survival-and-treatment-evolution-in-european-multiple-myeloma-patients-2012-202 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-1q-gainamplification-in-multiple-myeloma-patients-treated-with-daratumumab-based-regimens 2026-08-17 monthly 0.7 https://rjrindex.com/articles/renal-amyloidosis-related-mortality-trends-and-disparities-a-retrospective-nationwide-analysis-usin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-mosunetuzumab-in-follicular-lymphoma-patients-previously-exposed-to-lenalidom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/uneven-gains-disparities-in-pneumonia-associated-mortality-among-myeloid-leukemia-patients-in-the-u 2026-08-17 monthly 0.7 https://rjrindex.com/articles/application-of-hi-c-sequencing-to-detect-cryptic-and-novel-structural-aberrations-in-lymphoid-neopla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/management-and-outcomes-of-acute-coronary-syndromes-in-patients-with-immune-thrombocytopenia-a-sing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-hemosil-and-innovance-antithrombin-assays-using-hemophilia-a-plasma-and-antithrombin-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/momelotinib-mediated-transcriptional-reprogramming-induces-synthetic-lethal-interaction-with-calcine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/update-aml-updated-disease-monitoring-and-treatment-to-enhance-outcomes-for-pediatric-aml-nct07059 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-and-clinical-response-to-bortezomib-thalidomide-and-dexamethasone-in-patients-with-multip 2026-08-17 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-hrqol-in-patients-with-relapsedrefractory-follicular-lymphoma-trea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/normal-b-cells-in-mbl-follow-divergent-maturation-pathways-that-correlate-with-the-ighv-mutation-sta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-bispecific-antibodies-into-va-oncology-care-a-multidisciplinary-protocol-and-education 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimation-of-post-transfusion-hba-level-is-relevant-after-rbc-exchange-in-sickle-cell-adult-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/moyamoya-syndrome-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/support-isnt-always-supportive-relational-and-cultural-misalignment-in-black-sickle-cell-disease-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tet2-clonal-hematopoiesis-enhances-thrombotic-pathologies-increases-platelet-reactivity-and-alters 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-crizanlizumab-in-sickle-cell-disease-a-systematic-review-and-meta-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-hyponatremia-in-non-hodgkin-lymphoma-patients-insights-from-a-7-year-nation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-long-term-anticoagulation-use-in-patients-hospitalized-with-sickle-cell-vaso-occlusive-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/critical-role-for-mll3-phd-domains-in-hsc-self-renewal-and-aml-suppression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-letermovir-timing-day-5-to-8-post-haplo-hsct-minimizes-ebv-dnaemia-without-compromisin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-multifunctional-degraders-of-ep300cbp-and-ikzf13-with-potent-anti-myeloma-activity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pulmonary-hypertension-as-an-independent-predictor-of-mortality-in-hospitalized-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-ebv-dna-methlyation-to-guide-antiviral-use-in-ebv-associated-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-rocbrutinib-the-fourth-generation-brutons-tyrosine-kinase-inhibitor-in-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/car-t-cell-therapy-for-refractoryrelapsed-primary-breast-lymphoma-a-retrospective-cohort-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacitidine-and-luspatercept-metronomic-therapy-for-intermediate-to-high-risk-myelodysplastic-syndr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/perceived-treatment-and-clinical-trial-access-barriers-in-relapsedrefractory-rr-follicular-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-patterns-of-bone-modifying-agents-for-multiple-myeloma-in-the-era-of-novel-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cell-free-application-of-deltex1-to-suppress-hyperactive-notch-signaling-in-t-cell-acute-lymphoblast 2026-08-17 monthly 0.7 https://rjrindex.com/articles/geriatric-hematologic-care-in-latin-america-results-from-a-regional-survey-of-hematology-centers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-post-transplant-cyclophosphamide-vs-tacrolimus-plus-methotrexate-for-gvhd-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/talquetamab-outcomes-from-practice-outside-of-clinical-trials-the-bital-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-outcome-of-composite-lymphomas-a-synthetic-cohort-approach 2026-08-17 monthly 0.7 https://rjrindex.com/articles/crisprcas9-mediated-cish-deletion-and-cd16a-upregulation-potentiates-adcc-in-nk-cells-against-relap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-oncofertility-contraceptive-guidance-in-chronic-lymphocytic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-on-crs-and-icans-in-patients-with-multiple-myeloma-receiving-bispecific-antibodies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burden-of-chronic-obstructive-pulmonary-disease-among-patients-with-hematological-malignancies-a-na 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-immunological-differences-of-anti-t-lymphocyte-globulin-and-anti-thymocyte-globulin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-real-world-data-analysis-of-morbidity-burden-and-healthcare-costs-in-idiopathic-multic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overall-survival-and-prognostic-factors-of-adult-patients-with-acute-promyelocytic-leukemia-in-the-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-experience-and-safety-of-venetoclax-in-the-treatment-of-patients-with-chronic-lymphocytic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sarcopenia-and-body-composition-predict-survival-and-reveal-immunometabolic-dysfunction-via-single-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-autoimmune-disease-on-clinical-outcomes-in-patients-undergoing-car-t-cell-therapy-a-real 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-palliative-care-utilization-among-patients-with-acute-myeloid-leukemia-aml-insight 2026-08-17 monthly 0.7 https://rjrindex.com/articles/babesia-induced-cytokine-storm-a-rare-cause-of-secondary-hemophagocytic-lymphohistiocytosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessments-of-minimal-residual-disease-in-high-risk-patients-from-benefit-phase-3-rand 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proteomic-landscape-of-histiocytic-neoplasms-advancing-precision-biomarkers-molecular-mechanism-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/humanized-anti-cd25-monoclonal-antibody-for-previously-treated-hemophagocytic-lymphohistiocytosis-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-patterns-clinical-outcomes-and-resource-utilization-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pola-r-chp-in-newly-diagnosed-primary-mediastinal-b-cell-lymphomahigh-efficacy-and-tolerability 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unfavorable-outcomes-in-pediatric-pax5r-b-cell-precursor-acute-lymphoblastic-leukemia-flt3-targetin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-analysis-of-iptacopan-in-paroxysmal-nocturnal-hemoglobinuria-a-real-world-retro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-clinico-biological-profiling-identifies-a-high-risk-epigenetic-signature-in-mantle-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-of-highly-heterogeneous-flt3-itd-variants-reveals-distinct-drug-response-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-prevalence-of-alternative-splicing-in-core-cohesin-subunit-mutated-aml-as-compared-to-stag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chromodomain-helicase-dna-binding-protein-chd2-interacts-with-tet2-and-regulates-lineage-defining-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd39-overexpression-in-aml-blasts-elicits-an-immune-suppressive-bone-barrow-microenvironment-via-g3 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-ash-consa-consortium-on-newborn-screening-in-africa-for-sickle-cell-disease-interim-updates-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cbfa2t3glis2-directly-represses-differentiation-and-is-required-for-amkl-disease-maintenance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-vdac1-to-induce-mitochondrial-dna-sting-signaling-and-lysosomal-cell-death-in-t-cell-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/females-affected-by-hemophilia-a-data-from-the-united-states-8check-program 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiologic-insights-into-early-onset-myelodysplastic-syndrome-a-longitudinal-seer-analysis-2000 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-stratified-treatment-strategies-in-transplant-eligible-newly-diagnosed-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/morbidity-and-mortality-in-128-otherwise-healthy-canadian-children-with-severe-iron-deficiency-anemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-related-differences-in-outcomes-and-treatment-patterns-of-iron-deficiency-anemia-in-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/duration-of-lymphopenia-after-car-t-cell-therapy-is-associated-with-increased-risk-of-non-melanoma-s 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-post-transplant-cyclophosphamide-based-graft-versus-host-disease-prophylaxis-after 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dnmt3a-mutant-hematopoietic-stem-cells-generate-alloreactive-t-cells-with-graft-vs-host-disease-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-ai-based-membrane-specific-pd-l1-and-immune-subtypes-as-predictive-biomark 2026-08-17 monthly 0.7 https://rjrindex.com/articles/combinations-of-high-risk-cytogenetic-events-in-multiple-myeloma-drive-distinct-immune-remodeling-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/daratumumab-and-venetoclax-based-combined-regimen-for-relapsedrefractory-t-lymphoblastic-leukemial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immunotherapy-resistant-all-cells-exhibit-selective-dependence-on-glutamine-and-specific-transporter 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pregnancy-outcomes-among-women-with-sickle-cell-disease-a-propensity-score-matched-analysis-approac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/geographic-demographic-and-risk-factor-profiles-of-acute-myeloid-and-acute-lymphoblastic-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serum-ferritin-changes-in-iptacopan-treated-patients-with-paroxysmal-nocturnal-hemoglobinuria 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-of-axatilimab-in-combination-with-azacitidine-in-advanced-phase-mpn-mds-mpn-overl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-outcomes-of-primary-central-nervous-system-lymphoma-treated-with-high-dose-me 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-and-outcomes-of-patients-with-relapsedrefractory-rr-diffuse-large-b-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transient-hepatic-reconstitution-of-thymic-factors-using-mrna-rejuvenates-t-cell-immunity-and-impro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-mgus-on-comorbidities-and-outcomes-in-patients-with-multiple-myeloma-a-propensity-matched 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-chronic-lymphocytic-leukemia-mortality-among-older-adults-with-renal-failure-in-the-united 2026-08-17 monthly 0.7 https://rjrindex.com/articles/what-can-pten-expression-tell-us-about-cml-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/msc-affect-the-sensitivity-of-cml-cells-to-tkis-through-mitochondrial-transfered-via-tunneling-nanot 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bms-986397-a-first-in-class-casein-kinase-1a-ck1a-degrader-in-patients-with-relapsedrefractory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cpx-351-is-effective-in-secondary-acute-myeloid-leukemia-regardless-if-defined-according-to-2016-or 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-cd33-snp-rs3865444-modulates-the-association-of-clonal-hematopoiesis-with-alzheimers-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mir-146b-restoration-in-t-large-granular-lymphocyte-leukemia-molecular-insights-for-a-new-therapeut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/establishing-the-impact-of-effective-donor-specific-antibody-dsa-desensitisation-in-haploidentical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiology-and-outcomes-of-patients-with-myeloproliferative-neoplasms-in-the-united-states-a-seer 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mds-without-clonal-marker-when-depth-outperforms-breadth 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-on-orelabrutinib-combined-with-anti-cd20-monoclonal-antibody-regimen-in-treati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stability-and-evolution-of-individual-level-biomarker-patterns-across-repeated-vaso-occlusive-crises 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-chaos-to-clarity-decoding-the-inflammatory-profiles-in-lower-risk-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/total-body-irradiation-and-cigarette-smoking-interact-to-increase-the-risk-of-lung-cancer-in-blood-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-persister-cells-and-evolution-of-tumor-clones-during-immunotherapy-and-at-minimal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-evaluation-of-the-hla-kir-interaction-models-may-predict-the-nk-alloreactivity-in-haplo-hsct-bas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/9-year-old-female-presenting-with-l-lower-leg-pain-diagnosed-with-erdheim-chester-disease-ecd 2026-08-17 monthly 0.7 https://rjrindex.com/articles/access-barriers-and-treatment-patterns-in-philadelphia-negative-myeloproliferative-neoplasms-ph-mp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/active-cancer-as-a-risk-factor-for-inappropriate-vte-prophylaxis-data-from-a-single-center-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oncogenic-aspp2k-a-novel-regulator-of-drug-resistance-and-tumor-progression-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-multi-institutional-study-evaluating-the-safety-and-efficacy-of-the-combination-of-lisoca 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognosis-analysis-of-autologous-hematopoietic-stem-cell-transplantatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-therapeutic-outcomes-in-neurolymphomatosis-a-22-year-cohort-study-from-mayo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/polatuzumab-vedotin-retains-potent-activity-against-cd79b-mutations-preclinical-and-clinical-effica 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-clinical-correlates-and-clonal-inferences-of-concurrent-splicing-factor-mutations-in-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-g-csf-in-combination-with-venetoclax-and-azacitidine-vag-in-treatment-of-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-based-therapy-remodels-t-cell-and-nk-cell-immunity-in-patients-with-chronic-lymphocytic-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-remissions-beyond-4-years-with-epcoritamab-monotherapy-long-term-follow-up-results-from-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elevated-tim3-expression-on-bone-marrow-t-cells-drives-immune-dysfunction-in-early-relapsed-blood-ca 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-orelabrutinib-combined-with-obinutuzumab-with-or-without-bendamus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cardiopulmonary-complications-during-pregnancy-as-a-risk-factor-for-cesarean-delivery-in-a-two-cente 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-predictive-factors-for-pod24-in-patients-with-previously-untreated-mantle-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-base-editing-enables-safe-and-efficient-knockout-of-elane-for-the-treatment-of-elane-associ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mll3-and-mll4-maintain-hematopoietic-stem-cell-multipotency-by-actively-opposing-a-b-cell-default-st 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterizing-thrombosis-in-acute-promyelocytic-leukemia-real-world-insights-from-the-middle-east 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-romiplostim-and-short-course-prednisone-as-first-line-therapy-for-elderly-immu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-case-for-cd38-targeted-therapy-in-multi-refractory-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-mechanistic-insights-for-irak1-and-irak4-signaling-provide-a-framework-for-the-development-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phased-variant-circulating-tumor-dna-ctdna-tracking-provides-limited-additional-power-in-predictin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-invasive-mds-diagnostic-algorithm-can-also-identify-pre-mds-and-distinguishes-normal-controls-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-implementation-science-approach-to-optimize-adoption-of-hematopoietic-cell-transplant-survivorshi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-clones-of-uncertain-significance-are-prevalent-in-cutaneous-t-cell-lymphomas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/interferon-induced-cell-senescence-as-a-novel-mechanism-of-eculizumab-resistance-in-transplant-assoc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/circadian-rhythm-disruption-impairs-car-t-cell-efficacy-by-promoting-an-immunosuppressive-tumor-micr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemias-with-ubtf-tandem-duplications-respond-to-combined-bcl-2-and-rna-polymerase-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-the-anti-aml-mechanisms-of-compound-zhebei-granule-via-integrated-network-pharmacology-tr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-random-survival-forest-model-for-adult-npm1-mutated-acute-myeloid-leukemia-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chn1-suppresses-b-cell-non-hodgkin-lymphoma-progression-via-aktmtor-pathway 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chimeric-antigen-receptor-t-cell-therapy-in-patients-with-coexisting-malignancy-and-autoimmune-disea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-study-of-roginolisib-in-combination-with-ruxolitinib-in-patients-with-myelofibr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-cml-and-the-all-inducing-isoforms-of-bcrabl1-differ-for-the-induction-of-genomic-instablity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-no-probe-cell-imaging-method-based-on-cd58-expression-in-diffuse-large-b-cell-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/favorable-safety-and-efficacy-in-a-phase-ii-trial-using-duvelisib-maintenance-after-autologous-stem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/azacytidine-combined-with-chop-regimen-for-the-treatment-of-newly-diagnosed-angioimmunoblastic-t-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asxl1-mutant-cells-suppress-dnmt3a-mutant-clonal-expansion 2026-08-17 monthly 0.7 https://rjrindex.com/articles/abstract-maternal-and-fetal-outcomes-of-pregnancy-in-essential-thrombocythemia-a-systematic-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-predictors-and-consequences-of-poor-graft-function-after-post-transplant-cyclophosphamide 2026-08-17 monthly 0.7 https://rjrindex.com/articles/neutrophil-count-is-an-independent-prognostic-indicator-in-early-t-cell-precursor-lymphoblastic-leuk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rare-cancer-rare-survivors-a-20-year-single-center-review-of-adult-t-cell-lymphomaleukemia-treatm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-analysis-and-clinical-implications-of-therapy-related-clonal-hematopoiesis-in-adolescent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-of-collecting-social-determinants-of-health-data-in-the-frontline-pediatric-acute-lympho 2026-08-17 monthly 0.7 https://rjrindex.com/articles/letermovir-cytomegalovirus-prophylaxis-in-hematopoietic-cell-transplantation-real-world-evidence-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ccr2-chemokine-receptor-promotes-hematopoietic-stem-and-progenitor-cell-mobilization 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-the-origin-and-plasticity-of-circulating-endothelial-cells-reveals-a-systemic-angiogenic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-care-in-second-line-management-of-nodal-peripheral-t-cell-lymphoma-from-the-lymphoma-epi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-investigator-initiated-frontline-trial-of-evorpacept-alx148-lenalidomide-and-rituximab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/administration-of-chemoterapy-at-home-for-unfit-hematological-patients-a-safe-and-cost-effective 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-infectious-complications-on-outcomes-after-allogeneic-hematopoietic-stem-cell-transplantat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-kidney-disease-risk-stratification-in-compound-sickle-cell-disease-variants-a-single-center 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-ctla-4-costimulatory-domain-mitigates-cytokine-related-toxicity-improving-the-anti-cancer-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synkir-310-split-signaling-based-kir-car-t-cell-therapy-achieves-faster-and-deeper-anti-b-cell-tumor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-manifestations-risk-factors-and-prognosis-associated-with-central-nervous-system-relapse-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-immune-desert-phenotype-underlies-therapy-resistance-in-lbcl-through-distinct-microenvironment-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/brd4-sustains-immunosuppressive-erythroid-precursors-to-compromise-car-t-cell-function 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-tracking-of-flt3-itd-architecture-reveals-length-dependant-impact-on-clonal-clearance-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/btki-in-the-peri-infusion-period-in-lymphoma-patients-receiving-cd19-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-delayed-platelet-recovery-and-lower-nadir-counts-with-adverse-outcomes-in-heparin-ind 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-quality-improvement-project-to-improve-the-delivery-rate-of-iv-iron-to-patients-admitted-with-seve 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-single-cell-spatial-proteomics-reveals-predictive-immune-and-stem-cell-signatures-in-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transfusion-burden-among-older-us-patients-with-relapsed-flt3-mutated-acute-myeloid-leukemia-treated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oral-etoposide-vs-intravenous-daunorubicin-plus-atra-rif-as-induction-therapy-for-low-risk-acute-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-stratification-of-newly-diagnosed-aml-receiving-nonintensive-treatment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prolonged-venetoclax-ven-plus-hypomethylating-agent-hma-therapy-in-non-promyelocytic-aml-a-sing 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-global-pnh-patient-registry-real-world-data-on-pnh-symptom-burden-and-quality-of-life 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-evaluating-the-impact-of-satellite-clinics-on-car-t-therapy-access-in-the-rural-so 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sirolimus-plus-low-exposure-calcineurin-inhibitors-as-an-alternative-gvhd-prophylaxis-in-cni-intoler 2026-08-17 monthly 0.7 https://rjrindex.com/articles/luspatercept-in-patients-with-hematological-diseases-who-have-delayed-erythroid-recovery-after-allog 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disproportionate-risk-of-hematologic-malignancies-in-sickle-cell-disease-scd-across-age-strata-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-evaluation-of-il2rg-blockade-in-patients-with-severe-aplastic-anemia-that-is-refracto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-timing-of-flt3-itd-dictates-evolutionary-trajectory-and-phenotypic-heterogeneity-in-acute-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-evaluation-of-venetoclax-combined-with-clag-regimen-in-relapsedrefractory-acute-myeloid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/germline-variants-and-their-role-in-the-pathogenesis-of-immune-effector-cell-associated-hemophagocyt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/systemic-mastocytosis-with-associated-lymphoid-neoplasms-sm-aln-a-distinct-subset-with-indolent-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patients-with-relapsedrefractory-multiple-myeloma-who-achieved-sustained-minimal-residual-disease-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/this-is-a-title-in-sentence-case-venetoclax-based-regimens-versus-intensive-chemotherapy-in-fit-old 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zanubrutinib-rituximab-and-high-dose-methotrexate-as-first-line-treatment-in-newly-diagnosed-prima 2026-08-17 monthly 0.7 https://rjrindex.com/articles/talquetamab-outcomes-in-relapsedrefractory-myeloma-with-extramedullary-and-paraskeletal-soft-tissue 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-the-high-risk-consensus-genomic-staging-system-in-newly-diagnosed-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/when-supportive-care-backfires-g-csf-induced-aortitis-unmasked-during-routine-adjuvant-chemotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-transplant-bendamustine-pt-ben-with-or-without-cyclophosphamide-for-gvhd-prophylaxis-after-ha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-tandem-bispecific-nanobody-car-sl1703-t-cells-targeting-cd19bcma-for-refractory-or-relapsed-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-the-histone-deacetylase-inhibitor-panobinostat-in-sickle-cell-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/health-care-resource-utilization-in-patients-with-multiple-myeloma-receiving-bispecific-antibody-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lime-a-first-in-class-of-live-bacterial-immune-engagers-for-cancer-immunotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-comprehensive-analysis-of-pcr-for-bcrabl1-and-next-generation-sequencing-ngs-based-measurable 2026-08-17 monthly 0.7 https://rjrindex.com/articles/engineering-quiescent-viral-entry-pathways-for-in-vivo-car-t-generation-via-binder-fusogen-combinato 2026-08-17 monthly 0.7 https://rjrindex.com/articles/strengthening-the-referral-pathway-community-oncology-clinician-perspectives-on-referring-to-academ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-10-year-retrospective-review-of-the-effectiveness-and-safety-of-tranexamic-acid-in-women-with-inhe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pirtobrutinib-vs-ibrutinib-in-treatment-naive-and-relapsedrefractory-cllsll-results-from-the-firs 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-bridging-therapy-corresponds-to-improved-outcomes-after-ciltacabtagene-autoleucel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-holding-therapy-prior-to-apheresis-on-outcomes-following-cd19-car-t-cell-therapy-in-large 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-teclistamab-in-combination-with-daratumumab-in-elderly-patients-with-newly-diagno 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-duration-subcutaneous-mosunetuzumab-demonstrates-sustained-clinically-meaningful-outcomes-in-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-clinical-study-on-the-combination-of-anti-pd1-monoclonal-antibody-with-lenalidomide-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-transfer-of-cd4-t-cells-reshapes-cd8-t-cell-differentiation-trajectory-in-humans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clpx-plays-pleiotropic-roles-in-heme-synthesis-and-erythropoiesis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/article-6a822c5c78974 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-experimental-characteristics-of-a-hereditary-thrombocythemia-family-with-co-mutation-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burden-of-comorbid-conditions-and-hospital-outcomes-in-sickle-cell-trait-patients-with-atrial-fibril 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-in-acute-myeloid-leukemia-mortality-among-patients-with-myelodysplastic-syndrome-in-the-unite 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-in-adolescents-and-young-adults-aya-a-comparative-analysis-of-global-and-usa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pegcetacoplan-for-patients-with-transplant-associated-thrombotic-microangiopathy-treatment-a-real-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanism-and-therapeutic-efficacy-of-the-xpo1-inhibitor-selinexor-in-refractoryrelapsed-ebv-positi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reporting-of-older-subgroups-in-registration-trials-of-fda-and-ema-approvals-between-2017-and-2023-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-retrospective-survival-outcomes-analysis-of-acute-erythroid-leukemia-patients-treated-with-upfront 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-scoring-system-for-epstein-barr-reativation-after-hematopoietic-stem-cell-transplantation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prospective-predictors-of-toxicity-of-bcmadirected-cart-therapy-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/7-day-venetoclax-combined-with-intensive-chemotherapy-as-induction-treatment-in-newly-diagnosed-acut 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adapted-physical-activity-during-first-line-therapy-in-multiple-myeloma-innovative-assessment-of-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/baseline-cytomegalovirus-igg-levels-predict-reactivation-in-patients-with-multiple-myeloma-receiving 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elritercept-shows-durable-responses-in-lower-risk-myelodysplastic-neoplasms-lr-mds-with-transfusio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatial-anatomical-genomic-heterogeneity-and-aberrant-somatic-hypermutation-define-clonal-evolution 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-at-diagnosis-drives-molecular-pathology-and-prognosis-in-diffuse-large-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-richter-syndrome-risk-and-survival-in-cll-the-role-of-targeted-therapy-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-cancer-associated-venous-thromboembolism-in-a-nationwide-electronic-healthrecord-dat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-thromboprophylaxis-using-direct-oral-anti-coagulants-doac-in-malignant-pediatric-tumors-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasmablastic-lymphoma-pbl-comparison-between-europe-latin-america-and-validation-of-the-pbl-int 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-the-relationship-between-serum-iron-patient-morbidity-mortality-and-length-of-hospitali 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-treatment-vaccine-seroprotection-is-markedly-lower-in-bcma-car-vs-cd19-car-recipients-with-limit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-progression-free-survival-with-venetoclax-consolidation-in-patients-with-high-risk-chronic-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dynamic-changes-in-the-bone-marrow-niche-following-cd19-targeted-car-t-cell-infusion-in-diffuse-larg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proteomics-reveals-cox7b-as-a-prognostically-relevant-oxphos-linked-protein-in-pediatric-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-standardized-rapid-dose-escalation-of-epcoritamab-for-patients-with-lymphoid-malignancies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/superior-disease-free-survival-of-allogeneic-hematopoietic-stem-cell-transplantation-in-elderly-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-and-risk-factors-for-new-overweight-or-obesity-following-hematopoietic-cell-transplantatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacokinetic-pharmacodynamic-modelling-of-von-willebrand-factorfactor-viii-prophylaxis-in-von-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/global-proteomic-profiling-of-tgrx-3247a-heterobifunctional-degrader-for-the-treatment-of-bcrabl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-multiple-myeloma-assessment-for-newly-diagnosed-patients-across-a-large-33-hospital-heal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sorafenib-enhances-anti-leukemia-effect-via-promoting-macrophage-nk-cell-immune-crosstalk-in-flt3-it 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-and-management-of-iron-deficiency-in-patients-with-bleeding-disorders-a-single-center-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/recombinant-von-willebrand-factor-for-perioperative-management-of-bleeding-in-pediatric-patients-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multi-modal-profiling-and-targeting-of-the-tumor-microenvironment-in-central-nervous-system-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/erythropoietin-stimulates-rapid-egress-of-erythroid-and-lymphoid-cells-via-the-cxcr4-cxcl12-axis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/filter-coagulation-related-risk-factors-associated-with-continuous-renal-replacement-therapy-in-crit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rising-cardiovascular-mortality-among-older-adults-with-coexisting-cancer-and-atrial-fibrillation-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-with-a-single-anthracycline-containing-cycle-in-younger-adults-with-newly-dia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-classification-of-hematological-malignancies-by-integrating-genomic-and-immune-reperto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/complement-inhibitor-use-is-not-a-significant-predictor-of-cancer-incidence-a-real-world-study-of-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relationship-of-sociodemographic-factors-to-presentation-and-natural-history-of-provoked-venous-thro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-myeloablative-vs-reduced-and-non-myeloablative-conditioning-in-mrd-negative-aml-and-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patient-reported-quality-of-life-in-chinese-children-with-b-cell-acute-lymphoblastic-leukemia-receiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-adjunctive-eptifibatide-or-argatroban-versus-control-for-acute-ischemic-strok 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-fxii-activation-in-endovascular-treated-stroke-patients-on-periprocedural-antithrombotic-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematologic-neoplasms-with-germline-ddx41-variants-experience-from-nine-spanish-centers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reduction-of-infections-with-intravenous-immunoglobulin-in-chronic-lymphocytic-leukemia-a-single-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-age-adjusted-mortality-rates-from-hemophagocytic-lymphohistiocytosis-hlh-2010-2023 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-between-body-composition-analysis-and-clinical-characteristics-in-diffuse-large-b-cell-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-and-safety-of-pomalidomide-rituximab-based-combination-therapy-in-newly-diagnose 2026-08-17 monthly 0.7 https://rjrindex.com/articles/estimating-the-united-states-cure-adjusted-prevalence-of-diffuse-large-b-cell-lymphoma-dlbcl-an-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/concurrent-clonality-of-multiple-hematopoietic-lineages-implications-for-pathogenesis-and-managemen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/srsf2p95h-and-nf1-deficiency-synergistically-activate-jak-stat-signaling-and-exacerbate-age-related 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparison-of-alemtuzumab-and-atg-based-conditioning-in-adult-recipients-of-allogeneic-hematopoietic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-sutimlimab-in-cold-agglutinin-disease-a-multicenter-trinetx-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-us-retrospective-observational-study-of-rituximab-initial-and-retreatment-in-patients-with-warm-au 2026-08-17 monthly 0.7 https://rjrindex.com/articles/propensity-score-matching-analysis-comparing-the-efficacy-and-long-term-outcomes-of-belumosudil-to-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/methimazole-triggered-pancytopenia-in-a-long-term-methotrexate-user-dual-agent-myelotoxicity 2026-08-17 monthly 0.7 https://rjrindex.com/articles/individualized-treatment-risk-stratification-using-histopathology-based-genomics-prediction-in-multi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/association-of-the-easix-score-with-survival-and-adverse-outcomes-in-a-large-elderly-hispanic-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-patients-with-co-occurring-hematologic-malignancies-and-heart-failure-in-the-uni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-center-evaluation-of-tcrav-t-cell-depletion-using-clinimacs-plus-platform-optimizing-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-determinants-of-therapeutic-response-to-nivolumab-in-relapsedrefractory-ptcl-an-integrat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-approaches-to-identify-cellular-vulnerabilities-in-tet2-dependent-mds 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fgf11-hif-1a-glycolytic-epigenetic-axis-drives-aml-progression-and-chemoresistance-via-metabolic-rep 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacokinetic-failure-of-obinutuzumab-due-to-massive-third-space-sequestration-in-a-patient-with-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-addition-of-ebv-and-c3-complement-risk-factors-formed-a-better-angioimmunoblastic-t-cell-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-a-cd19-directed-car-t-cell-therapy-for-relapsedrefractory-mantle-cell-lymphomasmc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/non-invasive-mantle-cell-lymphoma-risk-stratification-by-inference-of-tumor-proliferation-from-cfdna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chromosome-genomic-array-testing-cgat-improves-diagnostic-yield-in-patients-with-aml-and-mds-and-h 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiomics-guided-ex-vivo-drug-sensitivity-testing-in-relapsedrefractory-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/administration-of-off-the-shelf-expanded-most-closely-hla-matched-third-party-viral-specific-t-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/description-of-neurocognition-in-adult-sickle-cell-disease-patients-using-the-nih-toolbox 2026-08-17 monthly 0.7 https://rjrindex.com/articles/higher-helios-treg-levels-pre-and-post-car-t-infusion-are-associated-with-inferior-outcomes-in-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/25-year-trends-in-autoimmune-neutropenia-related-mortality-in-the-united-states-a-national-cdc-wond 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chick-embryo-xenograft-model-of-multiple-myeloma-recapitulates-immune-response-systemic-disseminati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-incidence-and-survival-of-acute-myeloid-leukemia-by-age-group-a-seer-based-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-shmt2-and-adam28-as-potential-mediators-of-nfic-pro-growth-effects-in-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-healthcare-resource-utilization-hcru-following-car-t-cell-therapy-in-us-patients-treate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/context-dependent-recruitment-of-co-factors-directs-runx1-activity-in-normal-and-leukemic-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hmga1-chromatin-regulators-drive-transcriptional-networks-governing-cell-cycle-progression-immune-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/overcoming-therapy-resistance-with-multi-targeted-car-t-cells-secreting-bispecific-antibody-bsab-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-aponermin-combined-with-immunomodulators-in-relapsedrefractory-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-duration-of-therapy-with-erythropoietic-stimulating-agents-is-predictive-of-overall-survi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/isa-pace-in-the-treatment-of-functionally-high-risk-multiple-myeloma-intermediate-results 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-atrial-fibrillation-on-hospitalized-patients-with-myeloproliferative-neoplasms-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd38bite-secretion-overcomes-antigen-escape-in-bcma-targeted-car-t-cell-therapy-for-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/renal-response-of-selinexor-bortezomib-pomalidomide-and-dexamethasone-in-newly-diagnosed-multipl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lymphocyte-kinetics-as-a-predictor-of-clinical-outcomes-following-car-t-therapy-for-non-hodgkin-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/other-cancers-in-patients-with-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-selection-of-fixed-duration-versus-continuous-therapies-for-treatment-naive-chronic-lymph 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-clonal-dynamics-of-alloreactive-car-t-cells-reveal-mechanisms-limiting-gvhd-risk-following-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/burden-and-outcomes-of-car-t-cell-therapy-toxicities-in-dlbcl-multiple-myeloma-and-b-all-a-nation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/carfilzomib-augmented-with-high-dose-melphalan-conditioning-regimen-enhances-response-in-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etoposide-can-be-safely-removed-from-induction-chemotherapy-without-impacting-survival-for-pediatric 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-17-induced-cd70-expression-promotes-t-cell-suppression-in-dlbcl-implications-for-immune-escape-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-and-immune-determinants-of-response-to-cd3-x-cd20-bispecific-antibodies-in-aggressive-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transfusion-dependence-is-associated-with-poor-survival-in-mds-h-and-mds-lb-while-transplantation-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-of-the-edmonton-symptom-assessment-system-esas-score-as-patient-reported-outcomes-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unravelling-the-epigenetic-drivers-of-chip-mdscmml-aml-progression-through-novel-methylation-se 2026-08-17 monthly 0.7 https://rjrindex.com/articles/matched-sibling-donors-still-provide-superior-survival-outcomes-in-older-patients-with-aml-in-second 2026-08-17 monthly 0.7 https://rjrindex.com/articles/preliminary-efficacy-and-safety-of-tt-01488-a-novel-non-covalent-reversible-btk-inhibitor-in-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-tbi-donor-age-and-transplant-era-on-outcomes-of-allogeneic-transplantation-in-acute-lymp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ibrutinib-plus-r-chop-followed-by-maintenance-in-untreated-abc-dlbcl-patients-with-ipi-2-a-first-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-differences-in-metropolitan-versus-nonmetropolitanrural-counties-in-the-us-an-analysis-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advancing-adoption-of-evidence-based-quadruplet-treatment-regimens-for-newly-diagnosed-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-mitochondrial-metabolism-to-suppress-neutrophil-overactivation-in-sepsis-therapeutic-pote 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-profiling-and-outcomes-of-ischemic-stroke-patients-with-immune-thrombocytopenia-a-multicen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-ephrin-a3-in-the-bone-marrow-niche-offers-a-promising-therapeutic-strategy-to-impede-hemat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-cml-patients-undergoing-hematopoietic-stem-cell-transplantation-in-the-era-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-sepsis-in-patients-with-leukemia-in-the-united-states-1999-2020-a-cdc-wonder 2026-08-17 monthly 0.7 https://rjrindex.com/articles/in-vivo-modeling-of-leukemic-evolution-in-elane-associated-severe-congenital-neutropenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chromothripsis-drives-high-risk-multiple-myeloma-by-copy-number-abnormalities-and-rewiring-the-epige 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-burden-of-hematological-malignancies-in-latin-america-and-the-caribbean-a-30-year-global-burden 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplantation-related-outcomes-in-chronic-myelomonocytic-leukemia-data-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlation-of-t-cell-fitness-of-apheresis-products-with-response-to-car-t-cell-therapy-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-hydrochloride-liposome-based-cmopr-regimen-achieves-superior-response-in-treatment-nai 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-extranodal-sites-of-lymphoma-on-clinical-outcomes-after-cd19-car-t-cell-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-simple-3-factor-pre-treatment-score-toranomon-prognostic-score-robustly-stratifies-progression 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-polatuzumab-vedotin-zanubrutinib-and-rituximab-pola-zr-in-untreated-elderly-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sequential-cd19cd22-car-t-cell-therapy-following-asct-shows-improved-efficacy-versus-car-t-alone-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dismantling-systemic-barriers-in-sickle-cell-disease-care-design-and-rationale-of-a-municipal-publi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/developing-a-protocol-for-bloodless-medicine-patients-undergoing-transfusion-free-kidney-transplanta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bzip-in-frame-mutations-might-abrogate-the-adverse-prognosis-of-therapy-related-cebpa-mutated-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-prime-edited-autologous-hematopoietic-stem-cell-therapy-for-the-treatment-of-p47phox 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characterization-and-risk-factors-of-anticoagulation-related-bleeding-in-patients-with-thrombotic-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validation-of-a-sickle-cell-disease-specific-ipsc-platform-as-a-preclinical-screening-tool 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-screening-outcomes-in-adolescents-and-young-adults-with-sickle-cell-disease-age-21-2 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sox11-skews-t-cell-development-and-synergizes-with-lmo2-and-mycn-to-form-t-cell-acute-lymphoblastic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mothers-of-children-with-fetalneonatal-alloimmune-thrombocytopenia-fnait-develop-significant-psyc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mmf-is-associated-with-higher-non-relapse-mortality-and-inferior-survival-in-amlmds-patients-receiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protein-c-exhibits-significant-differences-in-plasma-levels-and-tissue-expression-in-inbred-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tafasitamab-containing-regimens-in-relapsedrefractory-diffuse-large-b-cell-lymphoma-a-real-world-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-the-prognostic-value-of-fdg-pet-derived-markers-and-responses-in-polarix 2026-08-17 monthly 0.7 https://rjrindex.com/articles/deciphering-the-ikzf1-and-map4k2-protein-interactome-in-rasmut-multiple-myeloma-reveals-a-novel-regu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-approach-identifies-targeting-strategy-for-selective-aml-dependency 2026-08-17 monthly 0.7 https://rjrindex.com/articles/alternating-cycles-of-quiescent-and-proliferative-cell-states-determine-stemness-and-leukemia-initia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-analysis-of-phase-ib-trial-of-duvelisib-for-cytokine-release-syndrome-prophylaxis-in-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/data-structuring-and-performance-indicators-for-decision-making-in-oncology-and-hematology 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-of-elranatamab-in-patients-with-multiple-myeloma-in-japan-findings-fr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serum-cholesterol-levels-define-an-inverted-u-shaped-relationship-with-pbsc-mobilization-and-immune 2026-08-17 monthly 0.7 https://rjrindex.com/articles/plasma-cell-senescence-in-relapsed-multiple-myeloma-revealed-by-integrated-single-cell-rna-seq-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effects-of-vaso-occlusive-episodes-acute-kidney-injury-and-apol1-status-on-urine-albumin-concentra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-blinatumomab-for-ebv-viremia-and-ptld-following-allogeneic-hematopoietic-stem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/unexplained-thrombosis-and-profound-monocytopenia-in-an-adolescent-delayed-diagnosis-of-gata2-haplo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chest-imaging-prior-to-allogeneic-bone-marrow-transplant-a-retrospective-study-of-pre-transplant-wo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multi-timepoint-immune-profiling-model-for-differentiating-gvhd-and-infection-associated-diarrhea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-trends-of-chronic-lymphocytic-leukemia-and-pneumonia-in-the-united-states-1999-2023-a-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-luspatercept-in-patients-with-low-blasts-myelodysplastic-neoplasms-in-rea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-non-driver-mutation-characteristics-in-primary-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-risk-for-meningococcal-and-other-encapsulated-bacteria-infections-with-systemically-administered 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-a-phase-i-study-of-peposertib-in-combination-with-mec-in-patients-with-relapsed-or-refrac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/parental-replacement-therapy-with-iron-dextran-or-ferumoxytol-in-patients-with-iron-defiency 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kilimanjaro-challenge-the-use-of-red-blood-cell-functional-assessment-in-a-gene-edited-sickle-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/role-of-therapeutic-anticoagulation-in-kidney-transplant-recipients-with-thrombophilia-a-systematic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trials-in-progress-a-phase-i-study-of-loncastuximab-tesirine-and-rituximab-following-stereotactic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-autologous-transplant-asct-in-patients-with-chemosensitive-late-relapse-of-large-b-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/divergent-exhaustion-networks-define-memory-cd8-t-cell-subset-fate-under-chronic-stimulation-and-re 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-and-results-of-retreatement-after-obinutuzumab-venetoclax-in-first-line-cll-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-infection-timing-and-burden-in-multiple-myeloma-patients-treated-with-teclist 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-rates-of-tyrosine-kinase-inhibitor-prescription-approval-fill-and-adherence-and-associa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-comparison-of-real-world-outcomes-of-asciminib-versus-atp-competitive-tyrosine-kinase-inhibitors-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lower-dose-emicizumab-prophylaxis-in-children-with-hemophilia-a-real-world-outcomes-hemostatic-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ddx6-undergoes-phase-separation-to-modulate-metabolic-plasticity-and-chemoresistance-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcrabl1gusb-halving-times-predict-molecular-response-to-asciminib-at-18-months 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-evaluating-the-feasibility-and-usability-of-an-mhealth-application-scd-warrior 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-outcomes-in-patients-with-myelofibrosis-who-presented-with-thrombo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-real-world-experience-with-revumenib-outside-of-a-clinical-trial-setting-a-single-center-retr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ropeginterferon-alfa-2b-in-essential-thrombocythemia-of-all-risk-levels-ineligible-for-standard-cyto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hematological-and-clinical-improvements-with-elritercept-ker-050-tak-226-at-the-recommended-phase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/subgroup-analyses-from-the-randomized-phase-3-verona-study-of-venetoclax-with-azacitidine-venaza 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-of-diffuse-large-b-cell-lymphoma-patients-with-rituximab-induced-acute-thrombocytope 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-i-dose-escalation-and-expansion-trial-of-lyt-200-a-first-in-class-anti-galectin-9-antibody 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dipss-r-a-revised-age-agnostic-clinical-risk-model-for-chronic-phase-primary-myelofibrosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustained-efficacy-of-zanubrutinib-zanu-vs-bendamustine-rituximab-br-in-treatment-tx-naive-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcma-car-t-cell-therapy-in-newly-diagnosed-primary-plasma-cell-leukemia-ineligible-for-transplantati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-efficacy-of-blinatumomab-combined-with-pembrolizumab-in-patients-with-relapsedrefractory-rr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/advancing-sickle-cell-disease-diagnosis-in-low-resource-settings-using-gazelle-a-paper-based-micro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-multi-omic-profiling-identifies-molecular-subtypes-and-predicts-outcomes-in-newly-diagnos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-risk-of-thromboembolic-events-in-patients-with-post-acute-sequelae-of-covid-19-a-retrospe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sickle-cell-disease-treatment-with-arginine-therapy-start-results-of-a-phase-3-randomized-contro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reprogramming-car-nk-cells-with-il-7il-7ra-to-amplify-stat1-signaling-and-activate-bystander-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-specific-impact-of-apoptosis-gene-expression-and-recurrent-mutations-on-remission-and-survival-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frequency-and-impact-of-flt3-itd-microclones-in-younger-aml-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/curcumin-and-resveratrol-sensitizes-tp53-mutant-acute-myeloid-leukemia-aml-cell-lines-to-venetocla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/detection-of-acute-myeloid-leukemia-and-related-hematologic-malignancies-by-machine-learning-using-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-analysis-of-a-multicenter-open-label-phase-2-study-of-sonrotoclax-bgb-11417-monotherapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-results-of-jnj-5322-a-novel-next-generation-bcmagprc5dcd3-trispecifi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correction-of-ineffective-erythropoiesis-and-durable-clinical-benefit-with-exagamglogene-autotemcel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-lnp-delivery-of-an-rna-gene-writer-in-vivo-enables-generation-of-functional-car-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-real-world-safety-and-efficacy-of-bispecific-t-cell-engager-therapy-in-systemic-al-amyloidosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictors-of-health-related-quality-of-life-in-adults-with-chronic-lymphocytic-leukemia-or-small-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-trajectories-of-patients-with-aggressive-b-cell-lymphomas-treated-wit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-use-safety-and-efficacy-of-teclistamab-with-or-without-prophylactic-tocilizumab-in-rela 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-linvoseltamab-as-a-simplified-monotherapy-first-line-regimen-in-ndmm-initial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-kite-753-or-kite-363-in-patients-with-relapsedrefractory-b-cell-lymphoma-initia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iberdomide-maintenance-after-autologous-stem-cell-transplantation-in-newly-diagnosed-multiple-myelom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-in-hospitalized-tuberculosis-patients-incidence-racial-disparities-and-fac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapid-efficient-and-durable-fetal-hemoglobin-production-following-cs-101-treatment-in-transfusion-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sonrotoclax-bgb-11417-monotherapy-in-patients-with-relapsedrefractory-rr-mantle-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/polyclonal-somatic-gene-rescue-via-uniparental-disomy-confers-multilineage-hematopoietic-potential-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-and-therapies-for-pure-red-cell-aplasia-in-patients-with-chronic-lymphocytic-leukemi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pivekimab-sunirine-in-blastic-plasmacytoid-dendritic-cell-neoplasm-in-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-single-arm-open-label-multicenter-study-efficacy-of-adjunctive-brutons-tyrosine-kinase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-of-ravulizumab-use-in-pregnancy-insights-from-a-global-pharmacovigilance-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/benefits-of-hydroxyurea-in-hemoglobin-sc-results-of-the-open-label-phase-of-the-prospective-identif 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-azacitidine-chidamide-plus-cag-cacag-ven-versus-37-induction-chemotherapy-in-interm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-addition-of-a-tyrosine-kinase-inhibitor-to-intensive-chemotherapy-significantly-improves-outcome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/auto-hsct-combined-with-blinatumomab-as-an-allo-hsct-sparing-strategy-in-newly-diagnosed-b-all-phas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/durable-responses-in-the-updated-2-year-follow-up-of-patients-from-a-single-center-with-relapsedref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/population-pharmacokinetics-poppk-and-exposure-response-er-analyses-of-lbl-034-a-potent-gprc5d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-romiplostim-n01-for-refractory-aplastic-anemia-a-retrospective-singlecenter 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genetic-landscape-of-hemophilia-a-in-korea-insights-from-precision-diagnosis-in-hemophilia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-implementation-readiness-of-machine-learning-in-hematologic-malignancy-imaging-a-scoping-r 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-chronic-pain-on-acute-pain-trajectories-in-sickle-cell-disease-insights-from-the-sickle-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multiomic-signatures-of-durable-response-in-a-phase-iii-trial-of-tandem-acd22-acd19-car-t-therapy-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-study-reveals-the-high-efficacy-and-well-tolerance-of-venetoclax-combined-with-homoharringt 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-clinical-study-on-intensifying-idarubicin-dosage-for-inducing-remission-in-acute-myeloid-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-atraatorifvenetoclax-combination-therapy-in-the-treatment-of-adult-acute-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/smoking-and-chronic-kidney-disease-are-associated-with-expansion-of-tet2-clonal-hematopoiesis-of-ind 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-methods-for-enriching-microglia-nuclei-from-frozen-brain-samples-to-study-the-effect 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-outcomes-of-adult-t-cell-leukemialymphoma-across-world-regions-an-internatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-site-single-arm-pilot-study-of-cpx-351-vyxeos-in-individuals-amplt22-yea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-and-therapeutic-impact-of-flt3-mutations-and-allelic-burden-in-myelodysplastic-syndromes 2026-08-17 monthly 0.7 https://rjrindex.com/articles/soluble-immune-modulators-in-the-bone-marrow-microenvironment-predict-long-term-survival-in-pediatri 2026-08-17 monthly 0.7 https://rjrindex.com/articles/use-of-apixaban-for-the-prevention-of-thrombosis-in-children-with-coronary-artery-aneurysms-secondar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trials-in-progress-design-of-a-registrational-phase-2-trial-alloha-using-an-external-control-arm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/metabolism-focused-crispr-screen-in-b-cell-tumor-identifies-sphingolipid-metabolism-promotes-resista 2026-08-17 monthly 0.7 https://rjrindex.com/articles/improved-health-related-quality-of-life-hrqol-and-bleeding-scores-with-oral-bruton-tyrosine-kinase 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-characteristics-of-560-unfit-patients-with-aml-aged-above-65-years-a-single-center-analys 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-homoharringtonine-combined-with-venetoclax-and-azacitidine-in-primary-ref 2026-08-17 monthly 0.7 https://rjrindex.com/articles/benchmark-evaluation-of-large-language-models-in-acute-myeloid-leukemia-prognosis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-metabolic-vulnerabilities-in-acute-myeloid-leukemia-therapeutic-potential-of-l-asparagina 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-associated-with-opioid-use-disorder-in-hospitalized-patients-with-venous-thromboem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/serum-free-light-chain-escape-before-imwg-progression-a-predictive-marker-and-a-therapeutic-opportu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/machine-learning-augmented-prediction-of-tumor-metabolic-burden-and-survival-in-multiple-myeloma-usi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-transplant-conditioning-intensity-tci-score-and-minimal-identifiable-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-response-rates-and-early-treatment-patterns-with-venetoclax-and-azacitidine-from-the-prospectiv 2026-08-17 monthly 0.7 https://rjrindex.com/articles/siltuximab-versus-tocilizumab-for-the-management-of-car-t-cell-associated-cytokine-release-syndrome 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-mutations-rna-editing-deaminase-activation-as-a-dynamic-marker-to-track-stem-cell-fitness-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/siltuximab-mediated-suppression-of-crp-is-associated-with-clinical-response-in-idiopathic-multicentr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/aberrant-activation-of-clpp-exerts-multifaceted-anti-aml-activity-beyond-tumor-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-dose-iron-infusions-in-pregnant-women-are-effective-safe-and-well-tolerated 2026-08-17 monthly 0.7 https://rjrindex.com/articles/six-versus-eight-doses-of-rituximab-in-combination-with-six-cycles-of-chop-chemotherapy-in-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd38-targeted-radiation-is-effective-and-enhances-car-t-cell-recruitment-and-expansion-in-resis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-from-the-first-200-ordered-clinical-modified-ham-mham-functional-complement-tests 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-gsdmd-agonist-dmb-induces-synergistic-pyroptosis-and-apoptosis-in-diffuse-large-b-cell-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/malt1-inhibitor-suppresses-aml-by-inducing-mcpip1-expression-and-shows-synergy-with-venetoclax 2026-08-17 monthly 0.7 https://rjrindex.com/articles/structure-based-virtual-screening-was-performed-to-investigate-the-mechanism-of-action-of-dual-targe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/developing-epigenetic-synergistic-drug-combinations-with-albendazole-in-paediatric-acute-myeloid-leu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ph-like-b-cell-acute-lymphoblastic-leukemia-in-a-mexican-pediatric-cohort-molecular-features-and-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outpatient-administration-of-epcoritamab-monotherapy-for-relapsedrefractory-diffuse-large-b-cell-ly 2026-08-17 monthly 0.7 https://rjrindex.com/articles/easix-guided-risk-stratification-of-severe-coagulopathy-and-early-mortality-among-newly-diagnosed-ac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-with-emicizumab-prophylaxis-in-patients-with-hemophilia-a-in-china 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-treatment-of-patients-primary-refractory-or-with-sub-optimal-response-to-d-vtd-induction-an-ita 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-stratification-based-on-machine-learning-for-severe-cytokine-release-syndrome-in-rrmm-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-prolonged-thrombocytopenia-after-cd19-car-t-therapy-evidence-for-reduced-production 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-characteristics-and-outcomes-in-patients-with-von-willebrand-disease-treated-pr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-outcome-of-diffuse-large-b-cell-lymphoma-real-world-data-from-saudi-ar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cytotoxic-lymphoma-assessment-response-clyar-a-harmonized-compartment-based-consensus-response-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gmp-compliant-crisprcas9-gene-editing-of-b2-microglobulin-in-cord-blood-derived-megakaryocytes-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/turboid-based-proximity-labeling-reveals-sirt5-network-regulation-in-acute-myeloid-leukemia-cell-lin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/b-lineage-acute-lymphoblastic-leukaemia-disrupts-a-lepr-bone-marrow-stromal-niche-which-is-critical 2026-08-17 monthly 0.7 https://rjrindex.com/articles/haploidentical-hematopoietic-cell-transplantation-haplo-hct-using-ex-vivo-tcr-av-depleted-grafts-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/belantamab-mafodotin-belamaf-ocular-events-are-manageable-and-reversible-with-dose-modifications-g 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comprehensive-cost-analysis-of-4th-line-therapies-for-relapsedrefractory-multiple-myeloma-in-germ 2026-08-17 monthly 0.7 https://rjrindex.com/articles/technical-benchmarking-of-eight-machinelearning-algorithms-versus-penalized-logistic-regression-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intrathecal-chemotherapy-for-management-of-immune-effector-cell-associated-neurotoxicity-syndrome-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hemophagocytic-lymphohistiocytosis-in-the-community-real-world-evidence-and-insights-from-a-rare-il 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-polatuzumab-vedotin-based-regimens-in-the-treatment-of-diffuse-large-b-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-mrd-negativity-and-immune-dynamics-in-patients-with-transplant-ineligible-n 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lymphovision-a-lymphoma-specialized-foundation-model-for-histology-based-lymphoma-classification-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-relapse-and-post-relapse-outcomes-in-patients-with-philadelphia-chromosome-negative 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-spectrum-of-cd5-positive-cd23-negative-b-cell-lymphoproliferative-disorders-analysis-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-tale-of-two-settings-survival-disparities-in-cllsll-between-academic-and-community-cancer-progra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-of-bleeding-events-in-patients-with-chronic-lymphocytic-leukemia-treated-with-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-zanubrutinib-containing-regimens-in-patients-with-newly-diagnosed-mantle-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/associations-between-serum-asparaginase-activity-and-asparaginase-associated-toxicities-in-pediatric 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mid-treatment-csf-ctdna-and-myd88-clearance-outperform-pet-ct-in-predicting-response-and-survival-to 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-utility-of-ct-sinus-screening-in-the-pre-bone-marrow-transplant-evaluation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-survival-outcomes-of-pomalidomidebortezomibdexamethasone-in-newly-diagnosed-multiple-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etiologies-and-clinical-predictors-of-pediatric-eosinophilia-a-retrospective-analysis-from-a-tertia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phenotypic-landscape-and-clinical-outcomes-associated-with-promotor-tert-mutations-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-simplified-age-and-stage-sas-score-improves-os-prediction-after-allogeneic-stem-cell-transplan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-multi-center-phase-2-trial-of-isatuximab-lenalidomide-in-patients-with-high-risk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-cd20-conjugated-ghd-t-cell-therapy-via-unnatural-sugar-mediated-chemical-modification-for-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-and-5-year-overall-survival-in-older-adults-60-years-with-hodgkin-lymphoma-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/raising-hemoglobin-level-with-erythropoietin-improves-cerebral-but-not-muscle-tissue-oxygenation-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrated-genomic-and-immunophenotypic-profiling-of-histiocytic-disorders-reveals-therapeutic-impli 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-hepatitis-b-virus-reactivaton-in-hbsag-negative-anti-hbc-positive-patients-receiving-rituxi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-hepatitis-b-virus-infection-on-long-term-prognosis-in-b-cell-lymphoma-a-retrospective-coh 2026-08-17 monthly 0.7 https://rjrindex.com/articles/semantic-features-associated-with-outcome-in-patients-treated-with-car-t-therapy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/significant-improvement-of-bone-marrow-fibrosis-in-patients-with-chronic-myeloproliferative-neoplasm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-motixafortide-plus-g-csf-versus-plerixafor-plus-g-csf-for-stem-cell-mobilization-and-col 2026-08-17 monthly 0.7 https://rjrindex.com/articles/examining-the-role-of-u2af1-and-tet2-mutations-in-a-myeloid-malignancy-mouse-model 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-testing-for-genetic-markers-on-treatment-selection-and-clinical-outcomes-among-patients-wi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-characterization-of-pure-erythroid-leukemias-and-sarcomas-driven-by-nfiacbf 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-multiple-myeloma-patients-previously-exposed-to-bcma-targeted-therapies-in-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-follicular-helper-cells-are-mis-localized-in-idiopathic-multicentric-castleman-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-correlates-of-response-and-survival-with-venetoclax-plus-hypomethylating-agent-in-treatmen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissecting-complement-pathway-activation-after-allogeneic-hematopoietic-cell-transplant-results-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anemia-and-diabetes-related-mortality-in-older-adults-geographic-and-temporal-trends-in-the-us-199 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-intensive-immunosuppressive-therapy-combined-with-eltrombopag-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/construction-of-mindfulness-based-cancer-rehabilitation-training-program-for-malignant-hematology-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcma-car-t-cell-expansion-dynamics-and-toxicity-after-idecabtagene-vicleucel-and-ciltacabtagene-auto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orm-1153-a-cd123-targeting-degrader-antibody-conjugate-with-gspt1-degrading-payload-exhibits-potent 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-of-cardiovascular-disease-related-mortality-in-hematologic-malignancy-patients-a-population-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comorbid-copd-as-a-major-independent-predictor-of-post-discharge-morbidity-in-adults-hospitalized-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chromameter-measured-skin-lightness-a-novel-noninvasive-marker-for-liver-iron-in-thalassemia-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-efficacy-and-safety-of-luspatercept-in-myelofibrosis-associated-anemia-a-clinical-study-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-nlrp3-with-ofirnoflast-alone-or-in-combination-with-semaglutide-ameliorates-inflammatory 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bcl-2-inhibition-in-north-american-adult-t-cell-leukemialymphoma-preclinical-insights-and-early-cl 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-line-selinexor-plus-r-chop-for-high-risk-gcb-subtype-diffuse-large-b-cell-lymphoma-a-multi-ce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/favorable-outcomes-of-bridging-glofitamab-prior-to-anti-cd19-car-t-cell-therapy-in-patients-with-non 2026-08-17 monthly 0.7 https://rjrindex.com/articles/er-resident-chaperon-protein-disulfide-isomerase-pdia1-inhibition-restricts-and-eliminate-aberrant-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/quality-of-life-in-multiple-myeloma-a-scoping-review 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-novel-mzb1-directed-hla-dependent-car-t-cell-and-car-enhancer-therapy-in-mm-and-other 2026-08-17 monthly 0.7 https://rjrindex.com/articles/precision-targeting-of-immune-mediated-thrombotic-thrombocytopenic-purpura-ittp-with-chimeric-auto 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-clustering-informs-risk-adapted-conditioning-regimens-in-aml-with-pre-transplant-deep-remiss 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prognostic-model-integrating-disease-and-patientoriented-factors-identifies-pooroutcome-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/keeping-it-renal-results-of-applying-guideline-based-management-in-sickle-cell-nephropathy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-in-multiple-myeloma-a-nationwide-analysis-of-risk-factors-mortality-and-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-cd34-derived-mast-cells-provide-an-excellent-platform-to-assess-single-agent-and-combinatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/united-arab-emirates-first-population-based-acute-leukemia-registry 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-clinical-outcomes-among-patients-with-paroxysmal-nocturnal-hemoglo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-predicts-genetic-network-disruptions-to-overcome-car-t-resistance-in-mantle 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-intensity-purine-analogue-based-therapy-for-refractoryrelapsed-acute-myeloid-leukemia-rr-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-real-world-treatment-patterns-and-outcomes-of-olutasidenib-in-patients-with-mutated-is 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-clinical-case-study-the-potential-impact-of-maternal-anti-co4-antibody-on-pregnancy-conceived-by 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venous-thromboembolism-in-lymphoma-a-scoping-review-of-anticoagulation-strategies-and-clinical-outc 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multimodal-machine-learning-framework-to-predict-treatment-duration-in-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/arvenacogene-sanparvovec-a-novel-gene-therapy-for-hemophilia-b-results-from-a-phase-i-ii-first-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/kras-mutations-in-histiocytic-neoplasms-mutation-spectrum-and-response-to-mek-inhibition 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-conditioning-intensity-on-outcomes-after-unrelated-donor-hematopoietic-cell-transplantatio 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prototype-evaluation-of-a-digital-quality-of-life-tracker-for-patients-pts-with-chronic-myeloid-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-prospective-multicenter-real-world-study-of-glofitamab-in-chinese-patients-with-relapsed-or-refr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/successful-surgical-management-in-severe-hemophilia-a-patients-using-efanesoctocog-alfa-a-two-case 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-anti-thymocyte-globulin-on-graft-versus-host-disease-risk-among-hla-matched-related-donors 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacokinetic-and-pharmacodynamic-characteristics-of-emicizumab-in-chinese-pediatric-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-single-centre-comparison-of-thiotepa-treosulfan-versus-thiotepa-busulfan-based-conditioning-regime 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-rare-case-of-idiopathic-non-cirrhotic-portal-htn-in-a-patient-with-idiopathic-thrombocytopenia-pur 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-prevalence-of-inborn-errors-of-immunity-iei-related-gene-germline-variants-and-its-prognostic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/large-b-cell-lymphoma-following-cd19-directed-cart-cell-therapy-failure-impact-of-car-construct-on 2026-08-17 monthly 0.7 https://rjrindex.com/articles/abbreviated-anticoagulation-regimen-with-direct-oral-anticoagulants-is-safe-and-efficacious-in-the-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/post-operative-thrombocytopenia-in-on-versus-off-pump-coronary-artery-bypass-grafting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-minimal-residual-disease-detection-by-circulating-tumor-dna-in-hodgkin-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/dissecting-clonal-hematopoiesis-in-diffuse-large-b-cell-lymphoma-through-multi-compartment-genomic-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/reproductive-health-in-patients-with-primary-immune-thrombocytopenia-itp-receiving-rilzabrutinib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/revealing-oncogenic-enhancer-regulation-by-epigenomic-profiling-of-multiple-myeloma-and-plasma-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/assessment-of-thrombotic-risk-and-pathophysiological-mechanisms-of-splenectomy-associated-hypercoagu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/paradoxical-urban-mortality-penalty-in-sickle-cell-disease-a-20-year-national-analysis-revealing-ag 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-g0s2-in-flt3-aml-bone-marrow-microenvironment-and-metabolism 2026-08-17 monthly 0.7 https://rjrindex.com/articles/frontline-therapy-patterns-and-outcomes-in-chronic-lymphocytic-leukemia-a-real-world-multicenter-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-anemia-and-copd-related-mortality-among-adults-in-the-united-states-from-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-in-mortality-from-phlebitisthrombophlebitis-and-atrial-fibrillationflutter 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rhoifolin-an-inhibitor-targeting-the-aldh2-pkc-delta-axis-eradicates-mrd-in-chronic-myeloid-leukem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-an-online-bone-marrow-transplant-bmt-service-medical-education-platform-for-interna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/atypical-presentation-of-relapsed-multiple-myeloma-with-microangiopathic-hemolytic-anemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/beyond-remission-sexual-health-and-quality-of-life-in-survivors-of-acute-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/murine-modeling-of-cluster-1-diffuse-large-b-cell-lymphoma-reveals-transformation-from-marginal-zone 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-adjusted-comparison-of-survival-in-chronic-myelomonocytic-leukemia-with-and-without-allogeneic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-characteristics-and-treatment-outcomes-in-pnh-patients-prescribed-pegcetacoplan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/endothelial-srsf1-regulates-hematopoietic-stem-cell-function-in-the-bone-marrow-microenvironment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-variables-associated-with-the-development-of-cytokine-release-syndrome-after-bispecific-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-aponermin-carfilzomib-dexamethasone-based-regimens-for-relapsedrefractory-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploiting-arginine-auxotrophy-in-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-to-d 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clonal-evolution-of-pediatric-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-mk-1045-a-novel-cd19xcd3-t-cell-engager-in-participants-with-relapsed-or-refracto-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-of-women-who-have-beta-thalassemia-discovered-during-pregnancy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/semaphorin-4d-and-interleukin-1beta-complement-cascade-axis-are-key-drivers-of-disease-progression-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-for-low-income-patients-with-multiple-myeloma-a-national-retrospective-trend-analysis-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-immunoparesis-lymphopenia-high-serum-ferritin-and-suppression-of-the-non-invo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-term-effect-of-marstacimab-prophylaxis-in-hemophilia-a-and-b-on-target-joints-results-from-bas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/platelets-stabilize-factor-viiia-against-loss-of-activity-through-subunit-dissociation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-safety-and-pharmacokinetics-of-alpelisib-alp-in-pediatric-and-adult-patients-with-pik3c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/suicide-risk-management-protocol-srmp-for-presence-trial-in-adolescents-and-young-adults-ayas-li 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-evaluating-the-safety-and-efficacy-of-first-line-asparaginase-recombinant-erwinia-as 2026-08-17 monthly 0.7 https://rjrindex.com/articles/alacrity-a-phase-1b2-study-of-azd0120-bcmacd19-car-t-cell-therapy-in-participants-with-relapsed 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-of-primary-mediastinal-large-b-cell-lymphoma-a-single-center-study-in-china 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-use-of-eculizumab-and-tocilizumab-in-the-treatment-of-hyperhemolysis-syndrome-a-literature-revi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rare-occurrence-of-liver-failure-secondary-to-sickle-cell-crisis-and-its-management 2026-08-17 monthly 0.7 https://rjrindex.com/articles/asc4opt-96-week-results-asciminib-once-or-twice-daily-continues-to-be-highly-efficacious-and-demons 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-number-of-cd34-cells-employed-in-autologous-hematopoietic-stem-cell-transplantation-in-persons-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blood-heavy-metal-levels-and-risk-of-hematologic-cancer-in-us-adults-nhanes-2021-2023 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protein-degradation-of-mycgspt1-is-a-novel-treatment-modality-for-aggressive-t-cell-acute-lymphobla 2026-08-17 monthly 0.7 https://rjrindex.com/articles/robust-assessment-of-early-mrd-levels-could-further-improve-treatment-outcomes-in-low-risk-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-and-transcriptomic-signatures-of-extramedullary-multiple-myeloma-reveal-possible-drivers-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-impact-of-additional-cytogenetic-abnormalities-and-complex-karyotype-on-outcomes-of-adult-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-reconstitution-after-venetoclax-based-treatments-in-cll 2026-08-17 monthly 0.7 https://rjrindex.com/articles/exploring-experiences-and-perceptions-of-fertility-and-reproductive-technology-among-people-with-sic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/olverembatinib-mediated-deep-remission-improves-allogeneic-stem-cell-transplantation-outcome-in-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhanced-vla4-dependent-endothelial-cell-adhesion-underpins-the-higher-efficacy-of-car-inkt-over-car 2026-08-17 monthly 0.7 https://rjrindex.com/articles/treatment-strategies-and-outcomes-in-pediatric-patients-with-immune-thrombocytopenia-itp-undergoin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/immune-cell-tumor-engagers-site-via-morpholino-guided-self-assembly-for-precision-immunotherapy-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-insights-in-therapeutic-antibody-therapies-using-advanced-microscopy-techniques 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-throughput-screening-uncloaks-actionable-compounds-for-ttmvrara-aml 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-hct-creatinine-defines-sex-specific-risk-for-severe-tma-after-allogeneic-transplantation-a-repo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-rapid-gene-expression-profiler-predicts-tumor-responsiveness-and-patient-outcome-for-standard-of-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-the-jakrock-inhibitor-rovadicitinib-in-combination-with-the-bromodomain-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/from-co-occurrence-to-mutual-exclusivity-long-read-single-cell-rnaseq-atlas-of-healthy-human-bone-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-and-challenges-of-aiml-models-for-sickle-cell-disease-detection-in-blood-smears 2026-08-17 monthly 0.7 https://rjrindex.com/articles/changes-in-real-world-treatment-patterns-over-time-by-patient-characteristics-and-time-burden-of-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autologous-cd30car-t-cell-therapy-in-patients-with-relapsed-or-refractory-classical-hodgkin-lymphom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prevalence-incidence-and-outcomes-of-multiple-myeloma-patients-using-electronic-health-records-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/caramel-dual-targeting-cd123cd33-car-t-cell-as-a-bridge-to-allogeneic-transplantation-for-relaps 2026-08-17 monthly 0.7 https://rjrindex.com/articles/are-all-gelf-criteria-created-equal-utility-of-individual-gelf-criteria-as-guidance-for-treatment-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-phase-iii-trial-of-palbociclib-and-cpx-351-in-patients-with-acute-myeloid-leukem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pirtobrutinib-monotherapy-in-treatment-naive-chronic-lymphocytic-leukemia-a-bayesian-ne 2026-08-17 monthly 0.7 https://rjrindex.com/articles/superior-outcome-from-frontline-cord-blood-transfusion-combined-hla-full-matched-unrelated-donor-hem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/humanin-like-8-regulates-metabolic-fitness-and-anti-apoptotic-programming-in-cd19-car-t-cells 2026-08-17 monthly 0.7 https://rjrindex.com/articles/influence-of-hiv-status-age-and-ethnicity-on-survival-in-patients-with-burkitt-lymphoma-bl-and-di 2026-08-17 monthly 0.7 https://rjrindex.com/articles/safety-analysis-of-axatilimab-in-patients-with-chronic-graft-versus-host-disease-in-an-expanded-acce 2026-08-17 monthly 0.7 https://rjrindex.com/articles/secondary-acute-myeloid-leukemia-transformed-from-chronic-myelomonocytic-leukemia-is-strongly-resist 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-frontline-chemolight-r-pola-glo-trial-induces-high-and-durable-response-rates-in-elderly-an 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phenotypic-shift-from-primitive-to-monocytic-immunophenotype-is-unique-to-patients-treated-with-azac 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-rates-of-financial-toxicity-and-time-toxicity-in-patients-receiving-chimeric-antigen-receptor-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-mycosis-fungoides-from-self-reported-race-to-genetic-ancestry-analysis 2026-08-17 monthly 0.7 https://rjrindex.com/articles/molecular-and-structural-basis-of-pan-resistance-to-btk-targeting-therapies-via-btk-a428d-mutation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/precise-hl-trial-personalized-reduction-of-chemotherapy-intensity-through-ctdna-evaluation-in-advan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-pathological-features-of-patients-with-large-b-cell-lymphoma-relapsing-after-car-t-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-in-patients-with-acute-myeloid-leukemia-treated-with-ivosidenib-plus-aza 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-3-randomized-double-blind-placebo-controlled-study-of-axatilimab-and-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/low-dose-post-transplant-cyclophosphamide-for-gvhd-prophylaxis-in-haploidentical-stem-cell-transplan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/flag-ida-as-frontline-induction-improves-outcomes-in-pediatric-patients-with-core-binding-factor-or 2026-08-17 monthly 0.7 https://rjrindex.com/articles/apixaban-or-rivaroxaban-for-extended-anticoagulation-in-patients-with-venous-thromboembolism-a-post 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-ctx130-a-cd70-directed-allogeneic-car-t-therapy-in-adult-t-cell-leukemial 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-burden-on-the-risk-of-cytokine-release-syndrome-crs-in-patients-with-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-molecular-and-demographic-features-of-systemic-mastocytosis-analysis-of-a-large-cohort 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-eno1-and-chidamide-in-ptcl-nos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-management-and-healthcare-utilization-in-older-adult-patients-with-tp53-mutated-aml-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/1200-u2af1-mutations-reveal-distinct-clinicobiological-features-of-the-s34q157-co-mutation-subgro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-and-outcomes-of-mantle-cell-lymphoma-in-latin-america-a-multinational-cohort-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-miniaturized-electrophoresis-diagnostic-platform-in-usa-for-hemoglobinopathies-from-diagnosi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-ruxolitinib-therapy-for-steroid-refractory-acute-graft-versus-host-diseas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/consistent-benefits-of-pegcetacoplan-treatment-in-pnh-patients-with-and-without-a-history-of-aplasti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-n6-methyladenosine-methyltransferase-wtap-maintains-erythropoiesis-by-stabilizing-stat5a-mrna 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mechanical-thrombectomy-long-term-risk-for-venous-thromboembolism-recurrence 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pharmacologic-activators-of-immunoproteasomes-unmask-actionable-public-and-private-neoantigens-in-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rxr-agonist-irx4204-induces-ferroptosis-in-multiple-myeloma-via-hmox1gpx4-axis-and-enhances-lenalid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-evaluation-of-eln-2022-and-eln-2024-risk-stratification-in-newly-diagnosed-aml-patients-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/heme-regulated-eif2a-hri-is-required-during-iron-restriction-to-alleviate-ss-thalassemia-via-mtorc1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/longitudinal-immune-monitoring-in-patients-treated-with-cd19-and-bcma-car-t-cells-using-standardized 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-ccr7-ubiquitination-to-disrupt-protumoral-macrophages-a-nedd4-1-dependent-strategy-to-rev 2026-08-17 monthly 0.7 https://rjrindex.com/articles/novel-indirubin-3-monoxime-derivative-i3mv-8b-enhances-anti-cd38-monoclonal-antibody-efficacy-in-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/17p-loss-in-tp53-non-mutated-myeloid-neoplasms-confers-survival-comparable-to-tp53-mutated-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/correlation-between-real-world-rw-progression-free-survival-rwpfs-and-overall-survival-os-amon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mcl1-copy-number-gain-is-a-recurrent-mark-of-venetoclax-resistance-in-patients-with-chronic-lymphocy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-apoptotic-effect-by-the-combination-of-clk-inhibitor-ctx-712-and-bcl-2-inhibitor-abt-199 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatial-multiomics-reveal-a-critical-role-for-tim4-expressing-macrophages-in-blast-transformation-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-results-from-the-ongoing-pegcetacoplan-silo-of-the-international-paroxysmal-nocturnal-hemoglob 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ribosome-biogenesis-and-its-regulation-by-the-exportin-cse1l-are-targetable-vulnerabilities-in-chi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-alzheimers-disease-and-anemia-related-mortality-in-adults-aged-65-years 2026-08-17 monthly 0.7 https://rjrindex.com/articles/covid-19-convalescent-plasma-utilization-patterns-among-hospitalized-us-medicare-beneficiaries-age 2026-08-17 monthly 0.7 https://rjrindex.com/articles/protamine-overdose-associated-coagulopathy-in-the-setting-of-post-pci-rca-dissection-and-cardiac-tam 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bet-inhibition-targets-pathogenic-interstitial-macrophages-to-limit-antibody-mediated-fibrosis-in-br 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-novel-small-molecule-ddx5-inhibitors-for-treating-relapsed-andor-refractory-multiple 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anti-cd7-car-t-cell-therapy-for-ultra-high-risk-relapsedrefractory-t-alllbl-insights-into-lineage 2026-08-17 monthly 0.7 https://rjrindex.com/articles/multicenter-study-of-the-ion-ampliseqtm-liverpool-lymphoid-network-community-ngs-panel-for-molecular 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparable-outcomes-in-patients-aged-70-vs-amplt70-undergoing-allogeneic-transplantation-with-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-of-impementing-pre-marital-genetic-counseling-in-kano-northern-nigeria-using-the-cfir-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-genetic-landscape-of-lymphoma-insights-from-a-primary-immunodeficiency-ngs-panel-in-lymphoma-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/closing-the-gap-genetic-profiling-of-b-cell-lymphomas-using-integrative-whole-exome-and-whole-trans 2026-08-17 monthly 0.7 https://rjrindex.com/articles/myeloproliferative-neoplasm-driver-mutations-jak2calrmpl-in-chronic-myelomonocytic-leukemia-are 2026-08-17 monthly 0.7 https://rjrindex.com/articles/orelabrutinib-plus-rituximab-based-chemoimmunotherapy-regimens-in-relapsed-or-refractory-marginal-zo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/validated-pet-ct-metabolic-tumor-volume-threshold-identifies-high-risk-relapsedrefractory-lbcl-and 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mitoxantrone-liposome-combined-with-eac-autologous-transplant-conditioning-for-the-treatment-of-tnk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-treatment-evaluation-of-t-cell-lymphoblastic-lymphoma-in-chinese-childr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/implementation-of-2020-international-guidelines-in-acquired-hemophilia-insights-from-a-decade-of-na 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fractionated-gemtuzumab-ozogamicin-go-with-high-dose-cytarabine-hidac-based-induction-chemothera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolution-of-myeloma-bone-disease-over-time-comparison-of-selected-biomarkers-in-mgus-smm-and-acti 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-rna-sequencing-of-cerebrospinal-fluid-reveals-transcriptional-divergence-of-leukemia-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-analysis-of-the-mutational-landscape-of-acute-myeloid-leukemia-at-an-urban-tertiary-care-center 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-novel-bcl-2-inhibitor-bda-366-targets-the-tlr4-pathway-to-induce-leukemic-cell-differentiation-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-surpass-trial-a-phase-23-registrational-trial-of-ela026-in-subjects-with-treatment-naive-secon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-in-children-with-nci-standard-risk-b-acute-lymphoblastic-leukemia-treated-with-intensified 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-aml-survival-paradox-early-escalation-vs-sustained-remission 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mixed-autoimmune-hemolytic-anemia-as-a-rare-initial-presentation-of-systemic-lupus-erythematosus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-phase-1b-study-of-olverembatinib-hqp1351-combined-with-lisaftoclax-apg-257 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-the-rock2-inhibitor-belumosudil-for-chronic-gvhd-treatment-multicenter-retro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chronic-myeloid-leukemia-and-asxl1-mutations-a-distinct-entity-requiring-special-attention 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tp53-mutation-promotes-diffuse-large-b-cell-lymphoma-progression-via-mediating-lactylation-of-atp5e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-race-and-social-deprivation-on-outcomes-with-modern-day-induction-therapy-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-1q21-gainamplification-and-co-existing-cytogenetic-abnormalities-in-chin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effect-of-immunoglobulin-replacement-therapy-on-the-incidence-of-severe-infections-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-a-registrational-phase-2-study-of-lisaftoclax-monotherapy-for-treatment-of-patients-pts 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-acute-kidney-injury-on-mortality-and-resource-utilization-in-hospitalized-patients-with-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hdac-and-cdk-inhibitor-combinations-suppress-neutrophil-activation-in-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd19-expression-is-preserved-following-cd19-directed-monoclonal-antibody-therapy-with-tafasitamab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/leveraging-an-integrated-single-cell-atlas-to-understand-perinatal-bone-marrow-development 2026-08-17 monthly 0.7 https://rjrindex.com/articles/single-cell-rna-seq-uncovers-that-plerixafor-can-mobilize-more-monocyte-progenitor-cells-and-enhance 2026-08-17 monthly 0.7 https://rjrindex.com/articles/adult-onset-non-langerhans-histiocytosis-with-multisystem-involvement-and-sustained-remission-on-imm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/successful-fertility-preservation-during-curative-therapy-in-female-adolescent-sickle-cell-anemia-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-for-medicaid-recipients-with-multiple-myeloma-a-national-retrospective-trend-analysis-from 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proteogenomic-analysis-of-npm1-mutated-aml-reveals-clinical-heterogeneity-related-to-differentiation 2026-08-17 monthly 0.7 https://rjrindex.com/articles/autologous-hematopoietic-cell-transplantation-ahct-in-the-era-of-novel-therapies-for-multiple-myel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/proliferation-of-mature-plasmacytoid-dendritic-cells-in-runx1-mutated-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/data-update-of-a-single-arm-phase-ii-study-of-orelabrutinib-withwithout-rituximab-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pd-1cd20-dual-target-therapy-in-unfit-diffuse-large-b-cell-lymphoma-a-real-world-pilot-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pola-r-chp-in-previously-untreated-diffuse-large-b-cell-lymphoma-real-world-data-in-russia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/results-of-the-promise-study-from-30000-individuals-screened-for-monoclonal-gammopathies 2026-08-17 monthly 0.7 https://rjrindex.com/articles/racial-and-socioeconomic-disparities-in-transfusion-utilization-among-hospitalized-sickle-cell-disea 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rheological-effects-of-voxelotor-in-scd-a-double-edged-sword 2026-08-17 monthly 0.7 https://rjrindex.com/articles/caspase-411-alters-circulating-immune-cells-and-mediates-organ-damage-in-townes-scd-mice 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pregnancy-outcomes-in-alpha-thalassemia-major-a-population-based-analysis-using-the-national-inpati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sex-based-differences-in-sepsis-related-complications-and-mortality-among-hospitalized-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bridging-versus-non-bridging-chimeric-antigen-receptor-t-cell-therapy-in-rela 2026-08-17 monthly 0.7 https://rjrindex.com/articles/etranacogene-dezaparvovec-in-haemophilia-b-report-of-1st-patient-receiving-hemgenix-in-spain 2026-08-17 monthly 0.7 https://rjrindex.com/articles/hodgkin-lymphoma-in-a-patient-with-hemophilia-a-on-emicizumab-prophylaxis-a-case-report 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-outcomes-and-accessibility-of-matched-sibling-donor-transplantation-for-severe-hemoglobin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/partial-splenic-embolization-to-manage-thrombocytopenia-in-cancer-patients-case-series-and-review-o 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-lipophilic-statins-on-survival-outcomes-in-polycythemia-vera-and-essential-thro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-allogeneic-transplant-vs-hypomethylating-agents-in-high-risk-myelodysplastic-syndromes-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lachnospiraceae-mediated-bile-acid-metabolism-promotes-ileal-epithelial-regeneration-following-graft 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-outcomes-of-car-t-cell-therapy-versus-bispecific-antibodies-in-patients-with 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-tcr-diversity-and-recipient-stem-cell-persistence-predict-relapse-and-reveal-therapeutic-targe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integrating-clinical-features-long-term-outcomes-and-ngs-based-mutational-analysis-in-aya-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trials-in-progress-a-phase-ii-study-of-pemigatinib-in-patients-with-relapsed-or-refractory-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/trends-and-arima-based-forecast-of-sepsis-related-mortality-in-chronic-lymphocytic-leukemia-cll-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-next-generation-sequencing-minimal-residual-disease-ngs-mrd-positivity-pre-allogeneic 2026-08-17 monthly 0.7 https://rjrindex.com/articles/same-outcomes-different-odds-socioeconomic-disparities-in-pmbcl-care-across-us-cancer-centers 2026-08-17 monthly 0.7 https://rjrindex.com/articles/randomised-phase-ii-study-of-acalabrutinib-in-combination-with-r-chop-treatment-for-diffuse-large-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/enhancing-immunotherapy-efficacy-in-myeloma-with-a-novel-dual-action-mitochondrial-toxic-peptide-tha 2026-08-17 monthly 0.7 https://rjrindex.com/articles/long-read-direct-rna-seq-reveals-dynamic-mm-transcriptome-made-of-novel-isoforms-and-post-transcript 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-unified-nanopore-based-approach-for-direct-telomere-sequencing-and-genetic-diagnosis-in-inherited 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-ii-study-of-clia-cladribine-idarubicin-cytarabine-plus-tyrosine-kinase-inhibitor-tki-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-multivariable-prediction-model-for-early-mortality-in-multiple-myeloma-patients-with-renal-impairm 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-combined-effects-of-emicizumab-and-marstacimab-in-plasma-from-hemophilia-a-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/iron-deficiency-anemia-in-premenopausal-women-a-comparative-study-of-menstrual-blood-loss-and-malab 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-effectiveness-of-hetrombopag-in-patients-with-primary-immune-thrombocytopenia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/irf2bp2-mutations-activate-il-1v-mediated-nf-kb-signaling-and-confer-actionable-anti-il-1v-sensitivi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evolving-use-of-blast-percentage-thresholds-and-classification-systems-in-aml-clinical-trials-2022 2026-08-17 monthly 0.7 https://rjrindex.com/articles/inclusive-practices-for-safe-and-equitable-donor-assessment 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-temporal-evaluation-of-static-risk-prediction-in-polycythemia-vera 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rapidly-progressive-acute-chest-syndrome-is-associated-with-complement-mediated-cell-injury-in-adult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/incidence-of-asymptomatic-deep-vein-thrombosis-in-patients-with-tunneled-dialysis-catheters-undergoi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-profile-of-inaticabtagene-autoleucel-in-chinese-adult-patients-with-b-cell-acute 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-salvage-therapy-improves-survival-in-b-all-relapsing-after-cd19-car-t-a-multi-institutiona 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fuserg-fusion-represents-adverse-plus-risk-group-in-aml-patients-evidence-from-a-registry-based-m 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sustainability-and-cost-avoidance-of-reduced-inappropriate-red-cell-transfusion-at-community-hospita 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mc-mil-net-a-multi-cascaded-dual-stream-multiple-instance-learning-diagnostic-framework-for-castlem 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-axicabtagene-ciloleucel-axi-cel-as-consolidation-therapy-following-first-li 2026-08-17 monthly 0.7 https://rjrindex.com/articles/effects-of-race-sex-marital-status-and-urbanrural-setting-on-survival-in-patients-with-acute-mye 2026-08-17 monthly 0.7 https://rjrindex.com/articles/intensive-chemotherapy-bridging-to-allogeneic-hematopoietic-cell-transplant-in-relapsed-or-refractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/analysis-of-hematologic-improvement-hi-by-time-to-response-in-relapsedrefractory-acute-myeloid-le 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-randomized-study-of-conventional-chemotherapy-uproleselan-in-older-adults-with-acute-myeloid-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-iptacopan-in-chinese-patients-with-paroxysmal-nocturnal-hemoglobinuria-a-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/cd47-mediates-oxygen-responsive-activation-of-rbc-enos-during-circulatory-transit 2026-08-17 monthly 0.7 https://rjrindex.com/articles/time-to-transfer-the-clock-is-ticking-a-quality-improvement-project 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disrupting-a-new-nfkb-il-6-jak2-stat-cascade-with-novel-nfkb-inhibitors-reduces-primary-myelofibrosi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pulmonary-function-tests-performed-prior-to-car-t-cell-administration-could-be-instrumental-in-predi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/an-automated-platform-for-lentiviral-transduction-for-hsc-gene-therapy-promotes-fitness-of-hematopoi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/oncogeriatric-assessment-of-patients-with-chronic-lymphatic-leukaemia-over-65-years-old-undergoing-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tagraxofusp-and-low-intensity-chemotherapy-for-the-treatment-of-cd123-positive-relapsed-or-refractor 2026-08-17 monthly 0.7 https://rjrindex.com/articles/contextualising-and-tailoring-standards-based-audit-sba-processes-for-sickle-cell-disease-scd-ca 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-prognosis-of-197-pediatric-patients-with-refractory-cytopenia-a-single 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-biological-correlates-of-blast-transformed-chronic-myelomonocytic-leukemia-cmml-a-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discovery-of-bispecific-t-cell-engagers-targeting-the-non-mutated-regions-of-mutant-calreticulin-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/increased-type-i-interferon-signaling-is-a-hallmark-of-idiopathic-multicentric-castleman-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/developing-expert-consensus-for-specialist-e-consult-response-a-delphi-study-to-inform-graduate-med 2026-08-17 monthly 0.7 https://rjrindex.com/articles/every-step-counts-quantifying-vte-risk-across-various-mobility-levels-in-the-hospital-setting 2026-08-17 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-of-zanubrutinib-in-combination-with-rituximab-ifosfamide-carboplatin-and-etoposi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/patterns-of-presentation-treatment-and-survival-in-primary-mediastinal-b-cell-lymphoma-a-colombia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/gut-microbiota-related-lithocholic-acid-alleviates-cgvhd-induced-bronchiolitis-obliterans-syndrome-b 2026-08-17 monthly 0.7 https://rjrindex.com/articles/susoctocog-alfa-for-major-surgery-in-acquired-hemophilia-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-bridging-therapies-prior-to-car-t-cell-therapy-for-large-b-cell-lymphoma-real-world-analy 2026-08-17 monthly 0.7 https://rjrindex.com/articles/identification-of-small-molecules-that-selectively-target-jak2v617f-driven-cytokine-independent-mega 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-prognostic-value-for-survival-of-frailty-and-patient-reported-outcomes-in-relapsedrefractory-mu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/stratos-an-ai-driven-biomarker-signature-for-prognostic-risk-stratification-in-transplant-associate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-suicide-risk-in-hematologic-versus-solid-organ-malignancies-a-seer-based-competing-risk 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disseminated-intravascular-coagulation-an-uncommon-initial-manifestation-of-aml-presenting-with-emb 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-of-quadruplet-vs-triplet-induction-in-multiple-myeloma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/glucose-6-phosphatase-dehydrogenase-g6pd-serum-level-predicts-acute-monocytic-leukemia-differentia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/osimertinib-synergizes-selinexor-on-anti-tumor-effect-by-targeting-c-myc-in-t-cell-acute-lymphoblast 2026-08-17 monthly 0.7 https://rjrindex.com/articles/age-and-race-drive-adult-t-cell-leukemialymphoma-incidence-in-the-united-states-not-income-or-urba 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-patients-with-co-occurring-chronic-kidney-disease-and-venous-thromboembolism-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-ravulizumab-safety-and-effectiveness-in-advanced-age-patients-with-paroxysmal 2026-08-17 monthly 0.7 https://rjrindex.com/articles/covid-19-igg-antibodies-drive-endothelial-cell-activation-and-dysfunction 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-the-duffy-null-phenotype-on-hydroxyurea-dosing-and-clinical-outcomes-in-children-with-sick 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transfusion-burden-during-the-initial-induction-phase-in-acute-myeloid-leukemia-is-tightly-associate 2026-08-17 monthly 0.7 https://rjrindex.com/articles/characteristics-at-diagnosis-of-autoimmune-hemolytic-anemias-in-adults-first-results-from-a-prospec 2026-08-17 monthly 0.7 https://rjrindex.com/articles/therapeutic-targeting-of-the-recurrent-mutant-tp53r248q-neoantigen-by-t-cell-receptor-engineered-t-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clec2a-a-validated-cancer-specific-antigen-is-an-ideal-candidate-for-immunotherapeutic-targeting-i 2026-08-17 monthly 0.7 https://rjrindex.com/articles/utility-of-peripheral-blood-cell-free-dna-in-detecting-minimal-residual-disease-in-patients-receivin 2026-08-17 monthly 0.7 https://rjrindex.com/articles/chg-combined-with-venetoclax-and-azacytidine-as-induction-chemotherapy-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/genomic-insights-and-risk-stratification-in-aml-findings-from-a-uniquely-young-national-cohort-in-q 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-potential-factors-associated-with-treatment-outcomes-in-newly-diagnosed-elderly-aml-patients-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cladribine-combined-with-cytarabine-and-g-csf-in-eliminating-measurable-resid 2026-08-17 monthly 0.7 https://rjrindex.com/articles/t-cell-redirecting-therapies-in-multiple-myeloma-barriers-and-knowledge-gap-among-patients-communi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tumor-flare-pain-reaction-during-teclistamab-step-up-dosing-with-tocilizumab-prophylaxis-an-underre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/spatially-decoding-genotype-associated-epigenetic-landscapes-in-human-lymphoma-ffpe-tissues-via-epi-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-implications-of-epigenetic-age-acceleration-as-a-novel-biomarker-in-acute-myeloid-leukemia 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-belantamab-mafodotin-containing-regimens-on-renal-function-in-patients-with-relapsedrefra 2026-08-17 monthly 0.7 https://rjrindex.com/articles/homoharringtonine-added-to-clag-regimen-improves-outcome-of-pediatric-relapsedrefractory-aml-a-mul 2026-08-17 monthly 0.7 https://rjrindex.com/articles/erythroid-pim1-deficiency-promotes-hematopoietic-aging-via-junjund-activation-and-igkc-mediated-pro 2026-08-17 monthly 0.7 https://rjrindex.com/articles/expression-of-the-cancer-testis-antigen-prame-is-associated-with-response-to-immune-checkpoint-inhib 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-car-t-cells-expansion-and-tumor-burden-on-the-outcome-after-inotuzumab-ozogamicin-as-bridg 2026-08-17 monthly 0.7 https://rjrindex.com/articles/venetoclax-based-salvage-therapy-achieves-high-remission-rates-after-73-or-low-dose-cytarabine 2026-08-17 monthly 0.7 https://rjrindex.com/articles/race-matters-cytopenia-trajectories-after-chimeric-antigen-receptor-t-cell-therapy-in-a-single-cen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bone-marrow-transplantation-outcomes-in-obese-vs-non-obese-patients-a-multicenter-propensity-match 2026-08-17 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-by-analysis-of-circulating-tumor-cells-hormonal-and-inflammatory-biomarkers-in-plasma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-predictive-relapse-indicators-for-myeloma-t-cell-engagers-prime-model-for-myeloma-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fbxo7-tmed10-wnt-t-all 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-of-montelukast-in-reducing-the-incidence-and-severity-of-monoclonal-antibodi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-processes-for-adverse-event-management-for-bispecific-antibodies-for-diffuse-large-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/higher-busulfan-cumulative-exposure-predicts-better-thalassemia-free-survival-in-patients-with-beta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/bispecific-antibodies-serve-as-a-safe-and-effective-bridging-therapy-prior-to-cd19-car-t-cell-therap 2026-08-17 monthly 0.7 https://rjrindex.com/articles/socioeconomic-disadvantage-as-measured-by-area-deprivation-index-adi-impacts-survival-in-patient 2026-08-17 monthly 0.7 https://rjrindex.com/articles/elderly-acute-myeloid-leukemia-aml-with-npm1-or-flt3-itd-mutated-is-venetoclax-the-game-changer-a 2026-08-17 monthly 0.7 https://rjrindex.com/articles/national-trends-and-disparities-in-al-amyloidosis-related-mortality-among-multiple-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-resistec-study-dissecting-immune-correlates-of-resistance-and-response-to-teclistamab-in-real-w 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-c-terminal-to-lish-ctlh-e3-ligase-complex-modulates-myeloma-glucocorticoid-sensitivity-by-regu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-outcomes-of-epcoritamab-and-glofitamab-in-relapsedrefractory-aggressive-b-cell 2026-08-17 monthly 0.7 https://rjrindex.com/articles/smarcd1-subunit-of-swisnf-chromatin-remodeling-complexes-collaborates-with-p53-to-exert-an-oncogeni 2026-08-17 monthly 0.7 https://rjrindex.com/articles/optimizing-essential-complex-hematologic-care-for-patients-living-with-disabilities 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-phases-of-hematology-oncology-fellowship-a-single-site-qualitative-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-role-of-microbial-metabolites-in-fecal-microbiota-transplantation-in-patients-with-acute-gvhd-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/impact-of-cancer-and-therapy-on-the-epigenetic-landscapes-of-normal-cells-describing-a-novel-biomar 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-zanubrutinib-in-patients-with-non-igm-lymphoplasmacytic-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rising-sepsis-related-mortality-in-aplastic-anemia-a-us-population-based-analysis-of-temporal-tre 2026-08-17 monthly 0.7 https://rjrindex.com/articles/anthropometric-data-from-a-large-cohort-of-indian-sickle-cell-disease-subjects 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-loncastuximab-tesirine-and-rituximab-lonca-r-followed-by-dose-adjusted-ritu 2026-08-17 monthly 0.7 https://rjrindex.com/articles/synergistic-remission-of-refractory-cutaneous-t-cell-lymphoma-by-linperlisib-plus-venetoclax-via-ta 2026-08-17 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-uncovers-novel-bcrabl1-breakpoints-and-variants-in-leukemia-implications 2026-08-17 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-survival-in-splenic-marginal-zone-lymphoma-a-national-analysis-in 2026-08-17 monthly 0.7 https://rjrindex.com/articles/ras-mutations-negate-the-favorable-impact-of-npm1-in-older-patients-with-newly-diagnosed-acute-myelo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/maintenance-with-hypomethylating-agent-venetoclax-after-intensive-induction-chemotherapy-in-patien 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-evidence-based-diagnostic-scoring-system-for-fat-embolism-in-sickle-cell-dise 2026-08-17 monthly 0.7 https://rjrindex.com/articles/first-results-from-the-phase-1-study-of-apl-4098-an-oral-potent-gcn2-inhibitor-for-the-treatment-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/predictors-of-survival-with-and-without-allogeneic-stem-cell-transplantation-after-first-salvage-the 2026-08-17 monthly 0.7 https://rjrindex.com/articles/the-efficacy-of-cilta-cel-after-a-prior-bcma-directed-car-t-cell-therapy-in-relapsedrefractory-mult 2026-08-17 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-open-label-study-to-evaluate-safety-tolerability-and-efficacy-of-elranatamab-in-pati 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relapsed-diffuse-large-b-cell-lymphoma-is-shaped-by-molecular-subtypes-and-genomic-alterations 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluating-artificial-intelligence-ai-as-a-clinical-decision-support-tool-for-aml-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-affinity-pd-1-cd28-switch-receptor-enhances-sustained-antitumor-activity-of-car-t-cells-in-both 2026-08-17 monthly 0.7 https://rjrindex.com/articles/disrupting-cxcl12-dpp4-gpc3-axis-redistributes-leukemia-stem-cells-and-confines-aml-cells-within-bon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-features-associated-with-glucolipid-metabolic-disorders-and-cardio-cerebro-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/avapritinib-achieves-deep-and-durable-symptom-control-with-a-well-tolerated-safety-profile-in-ism-l 2026-08-17 monthly 0.7 https://rjrindex.com/articles/front-line-consolidation-with-car-t-therapy-in-newly-diagnosed-adult-ph-negative-b-acute-lymphoblast 2026-08-17 monthly 0.7 https://rjrindex.com/articles/survival-differences-in-transplant-ineligible-multiple-myeloma-patients-in-japan-and-taiwan-explori 2026-08-17 monthly 0.7 https://rjrindex.com/articles/mrd-guided-ibrutinib-plus-venetoclax-improves-outcomes-in-cll-patients-with-tp53-atm-or-notch1-abe 2026-08-17 monthly 0.7 https://rjrindex.com/articles/fixed-treatment-duration-mosunetuzumab-continues-to-demonstrate-clinically-meaningful-outcomes-in-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/sparse-whole-genome-sequencing-and-machine-learning-of-aml-genomes-reveals-novel-clinically-relevan 2026-08-17 monthly 0.7 https://rjrindex.com/articles/acute-myeloid-leukemia-aml-with-tp53-alteration-and-outcomes-after-allogeneic-hematopoietic-stem-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/initial-phase-1b2-study-results-with-sonrotoclax-bgb-11417-in-combination-with-carfilzomib-and-de 2026-08-17 monthly 0.7 https://rjrindex.com/articles/il-2-mutein-mediated-improvement-of-car-t-function-in-relapsedrefractory-diffuse-b-cell-lymphoma 2026-08-17 monthly 0.7 https://rjrindex.com/articles/monotherapy-update-from-phase-1-portion-in-phase12-trial-of-the-menin-mll-inhibitor-enzomenib-dsp 2026-08-17 monthly 0.7 https://rjrindex.com/articles/allogeneic-hsc-and-regulatory-t-cell-orca-t-engineered-cell-therapy-following-reduced-intensity-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-and-treatment-patterns-of-patients-with-primary-mediastinal-b-cell-lymphoma-after-car-t-cel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/prolonged-elranatamab-treatment-interruption-in-patients-with-relapsed-or-refractory-multiple-myelom 2026-08-17 monthly 0.7 https://rjrindex.com/articles/decoding-ddx41-clinical-impact-of-germline-and-somatic-mutations-in-77-high-risk-myeloid-neoplasm-p 2026-08-17 monthly 0.7 https://rjrindex.com/articles/tuscany-study-demonstrates-safety-and-efficacy-of-tuspetinib-plus-standard-of-care-venetoclax-and-az 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pregnancy-and-delivery-outcomes-in-women-with-hemophilia-a-and-b-a-multicenter-cohort-study-from-th 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pre-or-post-car-t-allogeneic-hematopoietic-cell-transplant-provides-relapse-free-survival-benefit-f 2026-08-17 monthly 0.7 https://rjrindex.com/articles/integration-of-longitudinal-ctdna-mrd-and-petct-enhances-prognostic-stratification-in-newly-diagnos 2026-08-17 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-thrombo-embolism-in-neonates-a-systematic-review-of-the-literature-and-call-to-act 2026-08-17 monthly 0.7 https://rjrindex.com/articles/pociredir-a-novel-oral-once-daily-fetal-hemoglobin-inducer-results-from-the-phase-1b-pioneer-study 2026-08-17 monthly 0.7 https://rjrindex.com/articles/high-remission-rates-with-flag-ida-venetoclax-in-acute-myeloid-leukemia-less-is-more-on-days-of-v 2026-08-17 monthly 0.7 https://rjrindex.com/articles/caplacizumab-for-pediatric-immune-thrombotic-thrombocytopenic-purpura-a-scoping-review-of-current-e 2026-08-17 monthly 0.7 https://rjrindex.com/articles/primary-results-from-equator-a-phase-3-double-blind-randomized-placebo-controlled-study-evaluating 2026-08-17 monthly 0.7 https://rjrindex.com/articles/discovery-of-first-in-class-calr-targeted-precision-adcs-delivering-a-cdk9degrader-payload-for-the-t 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeted-liver-assessment-and-the-role-of-biopsy-prior-to-gene-therapy-and-hsct-in-transfusion-depen 2026-08-17 monthly 0.7 https://rjrindex.com/articles/early-access-program-for-danicopan-alxn2040-as-add-on-treatment-to-eculizumab-or-ravulizumab-in-pa 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-of-a-high-affinity-antibody-specific-to-the-predominant-l-light-chain-amyloid-subtype-fo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/targeting-the-sdf-1cxcr4-axis-to-attenuate-pain-in-sickle-cell-disease-a-preclinical-evaluation-of 2026-08-17 monthly 0.7 https://rjrindex.com/articles/snh-119014-a-novel-pyruvate-kinase-activator-enhances-atp-production-and-reduces-oxidative-stress 2026-08-17 monthly 0.7 https://rjrindex.com/articles/backtracking-the-cellular-origins-of-etv6runx1-childhood-acute-lymphoblastic-leukemia-in-cord-bloo 2026-08-17 monthly 0.7 https://rjrindex.com/articles/feasibility-of-wearable-technology-for-remote-monitoring-in-high-risk-adults-with-sickle-cell-diseas 2026-08-17 monthly 0.7 https://rjrindex.com/articles/rituximab-lenalidomide-and-zanubrutinib-zr2-with-sequential-car-t-cell-as-first-line-therapy-for 2026-08-17 monthly 0.7 https://rjrindex.com/articles/selecting-the-optimal-bridging-therapy-for-b-all-a-multicenter-comparison-of-blinatumomab-inotuzum 2026-08-17 monthly 0.7 https://rjrindex.com/articles/evaluation-of-response-assessment-in-chronic-lymphocytic-leukaemia-using-measurable-residual-disease 2026-08-17 monthly 0.7 https://rjrindex.com/articles/blinatumomab-efficacy-differs-between-newly-diagnosed-and-relapsedrefractory-b-all-impact-on-mrd-c 2026-08-17 monthly 0.7 https://rjrindex.com/articles/outcomes-of-clinical-trial-screening-in-patients-with-myelodysplastic-syndromes-and-chronic-myelomon 2026-08-17 monthly 0.7 https://rjrindex.com/articles/equalizing-access-to-chimeric-antigen-receptor-car-t-cell-therapies-for-myeloma-patients 2026-08-17 monthly 0.7 https://rjrindex.com/articles/development-and-evaluation-of-a-protein-language-model-based-prediction-model-for-acute-graft-versus 2026-08-17 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-low-dose-vs-standard-dose-direct-oral-anticoagulants-for-secondary-preventio-1 2026-08-17 monthly 0.7 https://rjrindex.com/articles/transfusion-related-acute-lung-injury-trali-following-intravenous-immunoglobulin-infusion-in-a-pat 2026-08-17 monthly 0.7 https://rjrindex.com/articles/relationship-between-myeloma-cell-genomic-alternations-and-tumor-immune-microenvironment-in-bone-rel 2026-08-17 monthly 0.7 https://rjrindex.com/articles/thrombotic-manifestations-in-gata2-deficiency-a-systematic-review-of-frequency-and-clinical-spectru 2026-08-17 monthly 0.7 https://rjrindex.com/articles/zip-code-drug-conjugates-zdcs-ctdna-guided-therapy-shows-strong-efficacy-and-low-toxicity-in-vitr 2026-08-17 monthly 0.7 https://rjrindex.com/articles/lentiviral-vector-transduced-autologous-cd34-cells-with-fviii-transgene-for-gene-therapy-of-hemophi 2026-08-17 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-car-t-cell-therapy-vs-teclistamab-in-relapsedrefractory-multiple-myel 2026-08-17 monthly 0.7